Electroconductive Nanofiber Matrices for Muscle Regeneration by Tang, Xiaoyan
University of Connecticut
OpenCommons@UConn
Doctoral Dissertations University of Connecticut Graduate School
7-31-2018
Electroconductive Nanofiber Matrices for Muscle
Regeneration
Xiaoyan Tang
Institute of Regenerative Engineering, xiaoyan.tang@uconn.edu
Follow this and additional works at: https://opencommons.uconn.edu/dissertations
Recommended Citation
Tang, Xiaoyan, "Electroconductive Nanofiber Matrices for Muscle Regeneration" (2018). Doctoral Dissertations. 1943.
https://opencommons.uconn.edu/dissertations/1943
  
 
Electroconductive Nanofiber Matrices for Muscle Regeneration 
Xiaoyan Tang, Ph.D. 
University of Connecticut, (2018) 
The treatment of rotator cuff tears of the shoulder is one the most common and challenging 
orthopedic problems. Tendon tears not only lead to pain but can also cause tendon thinning and 
retraction, fatty expansion and muscle atrophy. This subsequently can result in loss of shoulder 
stability and function. Clinically, surgical repair of tendons is performed to restore the connection 
between bone, tendon, and muscle. However, even after surgical repair, compromised tendon 
healing can be observed mainly due to fatty expansion into adjacent muscles. Preventing adjacent 
muscle degeneration and addressing fatty expansion is therefore critical to achieving favorable 
clinical outcomes after tendon repair.  
Among different approaches, the application of electrical cues has shown to promote muscle 
functional regeneration. The goal of this study was to engineer novel electrically conducting 
polymer matrices, which could help to retain muscle quality and enhance muscle regeneration after 
rotator cuff repair. Matrices were prepared by coating different concentrations of poly 
(3,4ethylenedioxythiophene): poly (styrenesulfonate) (PEDOT: PSS) (1%, 10%, 33%, 100%) on 
polycaprolactone (PCL) electrospun nanofiber matrices. The electrical conductivity, 
biocompatibility and the ability of the matrices to support muscle cell adhesion, proliferation and 
differentiation were studied using in vitro techniques. In vivo studies using rat rotator cuff acute 
and chronic repair models found that aligned electroconductive muscle matrices could guide and 
stimulate muscle regeneration, thereby suppressing fatty expansion. 
In summary, the study examined the feasibility of novel electroconducitve matrices to achieve 
high levels of muscle regeneration in the setting of rotator cuff tears.
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 1 
 
CHAPTER 1 INTRODUCTION 
1.1 Introduction 
Skeletal muscle is a critical component of the human body, consisting of 40-45% of an adult's 
body mass [1]. It is mainly responsible for generating forces which facilitate voluntary 
movement and locomotion [2]. When a moderate injury occurs, skeletal muscle has a robust 
ability to regenerate through the activation of muscle progenitor cells, also termed as satellite 
cells [3]. These satellite cells play a vital role in muscle regeneration as they not only participate 
during myogenesis but can also undergo a self-renewal process to maintain an undifferentiated 
population in the tissue niche [4]. Briefly, in response to injury, those quiescent satellite cells are 
activated. They will undergo proliferation, differentiate into myoblasts and further fuse to form 
multinucleated myofibers. These myofibers will then integrate into the functional muscle tissue 
[5].  
However, there is a limit to regeneration through satellite cell activation. Such mechanisms fail 
when more than 20% of muscle is lost due to trauma or chronic disease or surgery. The current 
standard approach for treating volumetric muscle loss involves either tissue debridement or 
muscle transposition [6]. Both procedures present a host of issues such as donor site morbidity 
and incomplete recovery of pre-injury muscle strength and functionality [2]. Regenerative 
engineering is a novel, alternative approach using the convergence of advanced materials 
science, stem cell research, physical sciences, and areas of developmental biology and clinical 
translation that has the potential to address muscle loss in moderate injuries with minimal to no 
scar formation and may also offer a regeneration strategy in the case of large volume muscle 
loss.  
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In this chapter, cell therapy treatment for muscle repair and regeneration, and the benefits of 
employing different types of biomaterials will be discussed. Also, the paper explores the 
incorporation of small molecules and drug release concepts for muscle regeneration strategies 
and discusses the impact of physical forces such as mechanical and electrical stimulation on 
regeneration. Translational studies involving volumetric muscle loss model and rotator cuff 
muscle injury will be discussed.  These studies examine the potential of regenerative engineering 
strategies to result in clinically meaningful results.   
1.2 Cell Therapy 
Muscular dystrophies are genetic myopathies, characterized by progressive muscle wasting and 
degeneration. The most common and severe form is Duchenne muscular dystrophy (DMD), 
which is caused by mutations in the dystrophin gene. Dystrophin is a structural component of 
myocytes and is responsible for maintenance of muscle fiber integrity, mediation of cytoplasmic 
signaling cascades and muscle functions [7]. The lack of functional dystrophin causes fragility of 
muscle fibers during contraction. Damaged fibers may be repaired by proliferation and fusion 
with activated proliferating satellite cells called myoblasts. However, the repaired fibers still lack 
dystrophin leaving them vulnerable to injury through successive contractions. This progressive 
and continuous faulty loop of degeneration and repair causes the myoblasts to rapidly senescence 
[8]. DMD patients lose mobility between 10 and 12 years of age and die from respiratory and 
cardiac failure by the third decade of life [9]. Unfortunately, there is still no cure for DMD. Cell 
therapy approaches for degenerative muscle diseases have received significant attention for 
treating these conditions. The cells used for transplantation can either be genetically corrected 
autologous cells from the patient or allogeneic cells from healthy donors [7]. 
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1.2.1 Satellite cells/Myoblasts 
Myoblasts were the first candidate cell types that were considered to treat muscular dystrophies. 
Myoblasts are satellite cell-derived progenitors with the ability to generate skeletal muscle. 
Studies performed in mdx mice (the most widely used animal model for DMD), demonstrated 
that intramuscular injection of myoblasts resulted in their fusion with host cells to form new or 
hybrid fibers, thus restoring dystrophin expression [10]. These encouraging results led to some 
clinical trials in the 1990s, however, failed to show significant clinical benefit. The major factors 
contributing to this unfavorable outcome were poor cell survival, limited cell migration and 
immune rejection of the transplanted cells, which drastically reduced their engraftment [11]. 
Over the years, numerous studies have addressed these challenges and worked towards 
overcoming them. A recent phase I/IIa clinical trial found that local injection of autologous 
myoblasts in the pharyngeal muscles of patients with oculopharyngeal muscular dystrophy 
(OPMD) is safe and efficient [12]. Myoblast cell therapy could be an effective treatment for 
localized and less extended muscular dystrophies. 
1.2.2 Muscle-derived stem cells (MDSCs) 
Several other cell populations, other than satellite cells/myoblasts, from the muscle, were 
subsequently investigated. Muscle-derived stem cells are postnatal stem cells identified and 
distinguished from satellite cells by their relatively low level of commitment to the myogenic 
lineage [13,14]. These cells are isolated from the skeletal muscle by the preplate technique, which 
enriches the population of slowly adhering MDSCs by eliminating the populations of more 
adherent cell types [15]. These cells offer several advantages over myoblasts such as high 
proliferative and self-renewal capability, multipotency, and immune-privileged behavior resulting 
in an overall improved transplantation efficacy compared to myoblasts/satellite cells [14,16]. 
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Notably, a population of poorly adherent MDSCs (known as MuStem cells) has been shown to 
contribute to myofiber regeneration, satellite cell replenishment, and long-term dystrophin 
expression in golden retriever muscular dystrophy dogs (the clinically relevant large model of 
DMD). When systemically injected, these cells contributed to partial remodeling of the skeletal 
muscle and enhanced regeneration resulting in a persistent stabilization of the dog's clinical status 
and major improvement in locomotion features [17,18]. There have been reports identifying the 
human analog of these muscle-derived cells [19,20]. However further studies will be needed before 
they can be evaluated for their therapeutic potential. 
1.2.3 CD133+ cells 
CD133 is a transmembrane protein expressed on a subpopulation of circulating human 
hematopoietic/endothelial progenitors. Torrente et al. showed that a subpopulation of CD133+ 
circulating cells expresses early myogenic markers. When injected systemically or intramuscularly 
in scid/mdx mice, they were found to contribute to muscle regeneration, replenishment of the 
satellite cell pool, and recovery of force [21]. Furthermore, their local injection appears to 
accelerate skeletal muscle regeneration through increased vasculogenesis [22]. CD133+ cells have 
also been isolated from human skeletal muscle. When injected intramuscularly in immunodeficient 
mice, these cells were more efficient in regenerating skeletal muscle than human myoblasts mainly 
due to their greater migratory potential and contribution to the satellite cell pool [23]. Also, a 
double-blinded phase I clinical trial assessing the safety of autologous transplantation of human 
muscle-derived CD133+ stem cells in DMD patients found no local or systemic side effects [24].  
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1.2.4 Mesoangioblasts 
Mesoangioblasts are vessel-associated stem cells that can differentiate into several mesoderm 
cell types including skeletal muscle [25]. In inflammatory conditions, such as in DMD, they have 
been shown to cross the vessel wall and colonize dystrophic muscles. This makes them cell 
candidates to be delivered systemically. Intra-arterial delivery of murine and canine 
mesoangioblasts has been shown to produce morphological and functional improvements in 
models of muscular dystrophy [26–29]. The human equivalent of mesoangioblasts expresses 
markers of pericytes, a subpopulation of muscle-resident cells. Human mesoangioblasts have 
also been shown to cross the vessel wall and participate in muscle regeneration in dystrophic 
muscles, restoring dystrophin expression [30]. Genetically corrected mesoangioblasts/pericytes 
isolated from DMD models have shown to produce dystrophin-positive muscle fibers in vivo 
[30,31]. Based on these pre-clinical studies, a phase I/II clinical trial for intra-arterial delivery of 
HLA-identical allogeneic mesoangioblasts to patients with DMD under immunosuppression was 
performed. The study proved to be relatively safe; however, minimal efficacy was observed, and 
the outcome was inconclusive regarding muscle function. Further studies are needed to 
determine the clinical benefit of mesoangioblasts for DMD patients [32]. 
1.2.5 Mesenchymal Stem Cells (MSCs) 
Mesenchymal stem cells isolated from several sources such as the bone marrow [33–38], synovial 
membrane [39,40], umbilical cord [41], and adipose tissue [42–46] have been identified for their 
myogenic potential.  
Adipose-derived stem cells (ADSCs) offer several advantages for cell therapy. They can be readily 
isolated from an accessible adipose tissue source with little patient discomfort or donor site 
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morbidity and expanded in large quantities [47]. Along with their multipotent differentiation 
capacity [48], immunomodulatory properties, and anti-inflammatory and paracrine effects [49], 
ADSCs are considered as one of the most promising and progressing stem cell populations for 
tissue regeneration. Rodriguez et al. were the first to report on the use of multipotent adipose-
derived stem cells (hMADs) for skeletal muscle regeneration in vivo. When injected into mdx mice, 
hMADs were able to restore dystrophin expression but failed to form myotubes [42]. Their 
myogenic potential can be improved by forced expression of MyoD. However, the clinical safety 
of lentiviral vectors has yet to be sufficiently proven [50].  Adipose tissue-derived cells have also 
been shown to promote regeneration in other types of muscular disorders such as hind-limb 
ischemia, limb-girdle muscle dystrophy (LGMD) or collagen VI-related muscle disorder 
[43,45,46]. Furthermore, human adipose-derived stromal cells have been shown to migrate, engraft 
and differentiate into muscle cells expressing dystrophin when administered intravenously into 
GRMD dogs, without immunosuppression [44]. The immuno-privileged behavior of adipose 
tissue-derived cells could be a significant clinical advantage for allogeneic cell therapy. 
Overall, the ability of mesenchymal stem cells to contribute to muscle regeneration and improve 
muscle function in vivo has not been conclusively established and requires further studies [34,36]. 
Nonetheless, because of their unique traits such as anti-inflammatory and immunomodulatory 
properties [51], availability from various tissues, and trophic effects that indirectly have a positive 
influence on repair and regeneration [52], MSCs are still being explored as candidates for muscle 
cell therapy.  
1.2.6 Embryonic stem (ES) cells and induced pluripotent (iPS) cells 
Pluripotent ES cells can differentiate into cells of all three germ layers and generate large 
numbers of specific cell populations, possibly overcoming the major obstacle of obtaining 
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sufficient numbers of cells for cell therapy. There have been many studies focused on deriving 
muscle precursor cells from ES cells that would be suitable for transplantation [53–57]; however, 
given the ethical concerns surrounding the use of ES cells, attention has shifted towards using 
iPS cells. Transplantation of patient-derived genetically corrected iPS cells offers the possibility 
of autologous cell therapy, reducing concerns of immune rejection and donor availability. 
Studies have reported successful generation of iPS-derived myogenic progenitors from patients 
with genetic muscular diseases. These cells have shown the capability to contribute to skeletal 
muscle regeneration upon transplantation [58–63]. Despite these promising results, safety and 
efficacy issues still need to be adequately addressed before these cells can be used clinically. 
1.2.7 Conclusion 
The skeletal muscle is the largest organ in the body that is systemically affected by degenerative 
muscular disorders. Therefore, a successful cell-based treatment would require systemically 
delivering a large number of cells that are capable of targeting and migrating towards the needed 
muscles. Studies so far indicate the potential of cell therapy for treating DMD. However 
successful treatment would necessitate optimizing the in vitro expansion conditions, improving 
the regenerative potential of cells and better understanding the role of the immune system and 
immune response.  
1.3 Conducting polymer  
Conducting polymers (CPs) are a new generation of organic materials first produced in the mid-
1970s. 
Research on CPs for biomedical applications expanded significantly in the 1980s when it was 
found that conducting polymers were compatible with many biological molecules. Numerous 
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applications are located such as neural probes,[64] neural prostheses [65][66]as well as controlled 
release applications.[67][68][69][70] [71]. A primary conductive polymer such as polypyrrole 
(PPy)[72][73] polyaniline (PANI) [74][72]polythiophene [75]and their derivatives[76][77][78][79] 
was developed, and their biocompatibility in vitro and in vivo was studied.   
More importantly, they have general properties that are desired for regenerative engineering 
applications including conductivity, reversible oxidation, redox stability, biocompatibility, 
hydrophobicity, three-dimensional geometry and surface topography[80][81]. 
Conductive polymers (CPs) can conduct charge because of the mobility of electrons within and 
between polymer chains. The uniqueness is that they possess a conjugated backbone formed by 
alternating single and double bonds, which makes particles easier to delocalize[82]. The crucial 
part of the conductivity of CPs is doping[81][83]. It is well known that before doping, CPs are 
generally insulative. Doping can result in a highly conductive polymer. The doping process is 
influenced by factors such as polaron length, chain length, charge transfer to adjacent molecules 
and conjugation length. For detailed mechanism, please refer to Bredas and Silbey’s book[84]. 
In one study done by Hsiao et al., aligned composite nanofibers of polyaniline (PANI) and poly 
(lactic-co-glycolic acid) (PLGA) were doped by HCl so that electrospun fibers could be 
transformed into a conductive form carrying positive charges, which could then attract negatively 
charged adhesive proteins such as fibronectin and laminin, promoting cell adhesion[85]. 
Additionally, attempts have been made to incorporate biologically active dopants, which have 
shown great promise in modifying conducting polymer-based materials[82]. For example, by 
synthesizing conducting polymers PPy onto the porous PES membrane using heparin as both 
ligand and dopant, a heparin-doped affinity membrane was developed. Adsorption capacity and 
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rate of thrombin on affinity electromembranes are significantly facilitated by electrical stimulation 
[77].  
1.3.1 Polypyrrole (PPy) 
There are several conducting polymers widely used in the biomedical engineering field. 
Polypyrrole (PPy) is by far the most studied conductive polymer. Today it has numerous 
applications in drug delivery, nerve regeneration, biosensor, as well as coatings for the neural 
probe, nerve guidance channel [86][87][88][89][70][90][91]. Below is the figure of the 
polypyrrole chemical structure. PPy possesses many attractive features that make it a promising 
candidate to study in the regenerative engineering field. First of all, it is stimulus responsive so 
that dynamic control of its properties is achieved by applying various electrical potentials[87]. 
More importantly, it has excellent in vitro and in vivo biocompatibility, excellent chemical stability 
and reasonably high conductivity under physiological conditions[92][93][94].  PPy has ease of 
synthesis in large scale with a wide range of solvents including water. It can also be fabricated in 
large surface areas with desired porosities. To make it applicable in biomedical applications, the 
incorporation of bioactive molecules has been used[95][64][96]. 
 
 
Figure 1.Chemical structure of polypyrrole 77 
However, it is difficult to further process PPy once it is synthesized, since the high degree of 
conjugation in the molecular backbone of PPy makes it very rigid, insoluble and poorly 
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processable. Therefore, one way to compensate for the shortcomings is to use it together with 
another polymer, combining the advantage of both materials. [97] [98] To give it flexibility, PPy 
has been deposited onto polyester and polyethylene terephthalate (PET) fabrics. [99][100] 
Composite structure has also been widely used. For example, PPy was used with PDLLA either 
deposited on its surface to make a film [94]or into its matrix as nanoparticles. Nanocellulose–PPy 
composites have also been created which exhibits excellent mechanical strength, flexibility, and 
durability while possessing high conductivity, high capacity, and a fast ion exchange speed[86]. 
For bone tissue engineering applications, in a study done by Sajesh et al. a Chitosan/ Polypyrrole–
alginate matrix was developed. MG-63 cells were loaded, and it was found that PPy based matrices 
supported cell attachment and proliferation. In vitro mineralization of the matrix suggested the 
bioactivity of the matrix and apatite layer formation. Based on these results, it was recommended 
that the matrix could be employed for bone tissue engineering using osteogenic cells.  Also, by 
combining electrical stimulation with a bioreactor system, further evaluation of the role of 
conducting substrates in bone regeneration can be studied[101]. 
For PPy with and without electrical stimulation, the Shimit group investigated electrospun matrices 
involving deposition of PPy on electrospun PLGA fibers. The PPy PLGA displayed electrical 
activity and nanofibrous features. In vitro cell culture using PC12 cells and embryonic 
hippocampal neurons demonstrated compatible cellular interactions, and that the fabricated PPy–
PLGA meshes are appropriate for neuronal applications and present topographies for modulating 
cellular interactions comparable to the PLGA control nanofibers. Finally, electrical stimulation of 
PC12 cells on the conducting nanofiber matrices improved neurite outgrowth compared to non-
stimulated cells. Besides, further increases in neurite length and percentage of neurite-bearing cells 
were observed with electrical stimulation on aligned conducting nanofibers. Studies have also 
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shown that electrical stimulation of polypyrrole(PPy) increases the adsorption of fibronectin(FN) 
from homogeneous FN solutions, as well as from serum correspondingly. These studies suggest 
that increased FN adsorption with direct electrical stimulation may explain enhanced neurite 
extension on electrically stimulated PP[102][103][89]. So far, PPy has been reported to support 
cell adhesion and growth of many different cell types[104][103]. 
Furthermore, other efforts have been made to improve the biocompatibility of PPy through 
modification, one example of this, as mentioned earlier, is the incorporation of bioactive 
molecules[95][64][96]. An amino acid peptide, T59, was bound to PPy and provided novel means 
of surface modification that does not reduce the bulk conductivity[105]. 
In another study, heparin was covalently immobilized onto electrically conductive polypyrrole 
(PPy) film through poly (ethylene glycol) methacrylate (PEGMA) graft copolymerization and 
subsequent cyanuric chloride activation. The PEGMA-graft-copolymerized PPy surfaces, with 
immobilized heparin, had good bioactivity, indicated by a low level of protein adsorption, a high 
ratio of albumin to fibrinogen adsorption, and low thrombus formation and the PPy film retained 
significant electrical conductivity after surface modification[95].  
1.3.2 Polyaniline 
Besides polypyrrole(PPy), polyaniline (PANI) has also been studied widely due to its attractive 
advantages such as ease of synthesis, tunable conductivity, environmental stability, and 
biocompatibility[86]. 
PANI exists in various forms based on its oxidation level: the fully oxidized pernigraniline base, 
half-oxidized emeraldine base, and sufficiently reduced leucoemeraldine base[83][86]. 
PANI can be synthesized by either chemical or electrochemical methods[106]. The advantage of 
an electrochemical method is that the production of a PANI film is uniform, of high purity, and 
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can be deposited and collected on a metal electrode[107].  However, more commonly, it is 
synthesized by chemical methods, by oxidative polymerization of aniline in aqueous media in the 
presence of an oxidizing agent. Other methods include but are not limited to emulsion, dispersion, 
solution, interfacial, metathesis and self-assembling[108]. 
 
 
Figure 2.Chemical structure of polyaniline(PANI)77 
PANI in its pure form demonstrates good biocompatibility both in vitro and in vivo and has been 
combined with a variety of biodegradable polymers to form composites having specific 
mechanical, electrical, and surface properties. [106] For example, electrically conductive 
composite of poly (l-lactide-co-ɛ-caprolactone) (PLCL) blended with polyaniline (PANI) was 
made using an electrospinning method.  C2C12 myoblast was seeded on those matrices. The 
results showed an increase in myotube number, length, and area with increasing PANI content. 
This indicates that electrically conductive substrates can modulate the induction of myoblasts into 
myotube formation even without additional electrical stimulation[109]. In another study, 
electrospun fibers were made using PANI doped with camphorsulfonic acid (CPSA) and blended 
with PLCL. The cell adhesion tests showed higher adhesion on CPSA-PAni/PLCL nanofibers than 
pure PLCL nanofibers using human dermal fibroblasts, NIH-3T3 fibroblasts, and C2C12. More 
importantly, the growth of NIH-3T3 fibroblasts is enhanced under the stimulation of various direct 
current flows[110]. 
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More efforts have been made to improve compatibility of PANi by either blending PANI with 
other biocompatible polymers, such as PCL and gelatin mentioned above or by immobilizing cell 
adhesive peptide sequences onto the PANI backbone. For example, in a study by Li and colleagues, 
the bioactive peptide sequences Tyr-Ile-Gly-Ser-Arg (YIGSR), and Arg-Tyr-Ser-Gly-Ile (RYSGI) 
were grafted onto PANI backbones, and the resulting cellular behavior and biocompatibility were 
compared with unmodified PANI. The result showed higher cell adhesion amount, and the grafting 
of adhesive peptides also improved proliferation of neuronal PC-12 cells. [111][106] 
No table of figures entries found. In recent years, Poly (3,4-ethylenedioxythiophene) (PEDOT) 
captured a considerable amount of attention driven by the advances of biotechnology. Compared 
to polythiophene, PEDOT has a dioxyalkylene bridging group across the 3- and 4-positions of its 
heterocyclic ring (Figure 3) greatly improving its properties by lowering its band gap, reduction, 
and oxidation potential[112]. This is also what grants PEDOT its good electrical, chemical and 
environmental stability as well as better conductivity and thermal stability than PPy[112]. So far, 
It is considered the most successful polythiophene derivative, with so many interesting 
properties[113]. 
1.3.3 Poly(3,4-ethylenedioxythiophene) (PEDOT)  
 
Figure 3.Chemical structure of (a) Polythiophene. (b) Poly(3,4-ethylenedioxythiophene)77 
Biocompatibility of this polymer has been studied. For example, in one study, epithelial cells were 
cultured on a PEDOT surface. The results showed that epithelial cells, Hep-2, present significant 
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activity on the surface of poly(3,4-ethylenedioxythiophene) electrodeposited on stainless steel 
electrodes and there is no sign of cytotoxicity[113]. 
In another study by Luo et al., NIH3T3 cells were seeded on synthesized PEDOT films, and 
biocompatibility was assessed. An in vivo study was done by subcutaneous implantation of 
PEDOT films. The results showed that PEDOT films exhibit very low intrinsic cytotoxicity and 
that their inflammatory response upon implantation was excellent, making them promising for 
biosensing and bioengineering applications[79]. 
PEDOT has also been chemically polymerized within acellular muscle tissue, where it formed a 
network of elongated tubular structures throughout the tissue due to the chemical and thermal 
stability of the PEDOT polymer depositions, it could be of great use for applications in peripheral 
nerve repairs as well as in biosynthetic prostheses [112]. 
 
Figure 4.Optical micrographs of mouse abdominal acellular muscle tissue (AMT) samples. 
Top row is images taken from 3-mm transverse sections; bottom row is images taken from 2-mm 
longitudinal sections, all at 40 magnification. In both rows, from left to right: (A) and (B) sonicated 
control AMT constructs; (C) and (D) sonicated AMTþ poly(3,4-ethylenedioxythiophene construct 
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subjected to 1 cycle of polymerization (PEDOT1) constructs, and (E) and (F) sonicated 
AMTþPEDOT6 constructs.[112]  
PEDOT has also been applied to neural electrodes. In one study, a neural electrode was interfaced 
with the surrounding brain tissue through the in situ polymerization of PEDOT. This formed 
PEDOT filaments are extending far enough away from the electrode to breach the glial scar around 
it and forming sensitive contacts with the plasma membrane of the neurons[114].  
When used in the drug release applications, PEDOT coated electrospun nanotubes were 
incorporated with dexamethasone.  It was reported that the drugs could be released from the 
nanotubes in a controlled fashion by electrical stimulation of the nanotubes [68]. 
In Martin’s group, a dual-component cochlear implant coating was also developed to improve both 
the electrical function of the implant and the biological stability of the inner ear. This coating 
combines an arginine-glycine-aspartic acid (RGD)-functionalized alginate hydrogel with poly(3, 
4- PEDOT). Both in vitro and in vivo assays on the effects of these electrode coatings demonstrated 
improvements in device performance. This coating is non-cytotoxic, clinically relevant, and has 
the potential to improve the cochlear implant user's experience[67] significantly.  
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1.4. Surface modification of tissue grafts 
There are both challenges and high demands for workable and straightforward surface 
modification in the biomedical research area. Inspired by the composition of adhesive proteins in 
mussels, Lee's group reported a simple and direct method to form multifunctional polymer coatings 
through simple dip-coating of objects in an aqueous solution of dopamine.[115] Dopamine self-
polymerization was able to build thin, surface-adherent polydopamine films onto a wide range of 
both inorganic and organic materials, such as noble metals, oxides, polymers, semiconductors, and 
ceramics. Secondary reactions can be used to create a variety of ad-layers, including self-
assembled monolayers through deposition of long-chain molecular building blocks, metal films by 
electroless metallization, and bioinert and bioactive surfaces via grafting of macromolecules.[115]  
 
 
Figure 5. Photograph of a mussel attached to commercial PTFE 
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 (B and C) Schematic illustrations of the interfacial location of Mefp-5 and a simplified molecular 
representation of appropriate amine and catechol groups. (D)The amino acid sequence ofMefp-5 
(13, 34). (E)Dopamine contains both amine and catechol functional groups found in Mefp-5 and 
were used as a molecular building block for polymer coatings. (F)A schematic illustration of thin 
film deposition of polydopamine by dip-coating an object in an alkaline dopamine solution. 
(G)Thickness evolution of polydopamine coating on Si as measured by AFM of patterned 
surfaces.[115] 
Such chemistry has been widely used in the tissue engineering field. For example, Tsai et al. 
reported poly(dopamine) deposition onto electrospun poly(ε-carprolactone) PCL to significantly 
promoted rat osteoblasts adhesion and proliferation. Mineralization was also increased on the 
poly(dopamine)-deposited surfaces[116]. This indicated that there is much potential of 
poly(dopamine) deposition in the tissue engineering field. 
1.5 Growth factors and small molecules in Skeletal Muscle Regenerative Engineering  
A common strategy in musculoskeletal regenerative engineering is the delivery of bioactive factors 
to stimulate the development of engineered tissue [117]. These signaling molecules can be 
incorporated within biomaterial-based matrix systems to enhance the proliferation and 
differentiation of stem cells and progenitor cells. Based on the properties of each factor and 
molecule, different encapsulation techniques may be used to modulate the release profile and 
maximize their desired therapeutic effect [118]. Two standard approaches are physical 
encapsulation, where the molecules are embedded within the biomaterial matrix during the matrix 
fabrication process, and chemical immobilization, where the bioactive factors are adsorbed or 
covalently bonded onto the surface of the structure [119,120].  
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In skeletal muscle regeneration, signaling molecules play an essential role in guiding the 
differentiation and proliferation of satellite cells into myoblasts, and eventually to multinucleated 
myofibers [121]. Growth factors are signaling proteins that through interaction with specific 
binding receptors, activate signal transduction pathways[119,122]. Major growth factors present 
throughout the skeletal muscle regeneration process include hepatocyte growth factor (HGF), 
insulin-like growth factor (IGF), fibroblast growth factor (FGF), transforming growth factor-b 
(TGF-b), and vascular endothelial growth factor (VEGF) [123–125]. (Fig. 1) illustrates the 
contribution of these growth factors during each stage of muscle regeneration [123]. 
Studies have shown the capability of incorporating growth factors within engineered skeletal 
muscle constructs to enhance regeneration both in vitro and in vivo. TGF-b1 plays a vital role in 
myogenesis through regulating satellite cell proliferation and differentiation, as well as promoting 
endothelial cell activity [125,126]. Weist et al. investigated the effect of TGF-b1 in improving the 
functionality of 3D skeletal muscle constructs. The muscle construct was derived from an adult rat 
tail tendon seeded with satellite cells [127]. At a TGF-b1 concentration of 2.0 ng/mL, a significant 
increase in the differentiation, contractility, and extracellular matrix deposition by the cells was 
observed. Studies have also shown that HGF and FGF-2 signaling play an important role in 
stimulating satellite cell activation and proliferation, and when delivered in unison, the therapeutic 
effects are significantly improved [128–130]. Hill et al. were able to develop an HGF and FGF-2 
dual delivery system using G4RGDSP peptide modified alginate polymer matrices to study their 
effects on myoblast migration and survival in vitro [131]. HGF and FGF-2 (250 ng) were added to 
the alginate solutions and subsequently gelled to form the matrix. The percent viability and 
migration of the myoblasts at day five within the peptide-modified matrices were significantly 
higher than the control and the HGF/FGF-2 separate groups. Similarly, VEGF has been studied as 
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a potential factor to stimulate neoangiogenesis and vascularization.[132,133] Analogous to HGF, 
IGF-1 can be utilized to trigger satellite cell differentiation and proliferation through the PI3K/Akt 
and Ras/Raf-1/ERK MAP kinase signaling pathways [134,135]. Borselli et al. explored the 
synergetic capability of delivering VEGF and IGF-1 to promote the repair of injured muscle within 
the ischemic hindlimbs of mice [136]. The mice were injected with 50 µL of alginate gel containing 
three µg of VEGF and IGF-1 either alone or in combination.  Subsequent data analysis illustrated 
that the sustained delivery of both growth factors restored the functionality of the skeletal muscle, 
with a reduction in ischemia. 
In spite of pre-clinical and clinical success with growth factor-mediated regeneration, certain 
limitations still exist. These include their high production cost, immunogenicity, 
supraphysiological dosage requirement, high market cost, and instability during the drug delivery 
formulation process [137,138]. The capability of harnessing the therapeutic potential of small 
molecules for musculoskeletal regenerative engineering applications, therefore, has raised 
interest[122]. Small molecules are organic compounds with a molecular weight of less than 1000 
Da. They can rapidly diffuse through the cellular membrane and regulate specific biological 
processes [139]. The inherent properties of these small molecules have resulted in improved 
stability, low production cost, and lower levels of immunogenic response compared to their growth 
factor counterparts [140,141]. However, due to the potential of non-specific side effects, the route 
of administration and dosage amount must be taken into account to maximize their 
pharmacological effect.  
Several small molecules have gained a significant level of interest within the realm of skeletal 
muscle regeneration. Sphingosine 1-phosphate (S1P) is a sphingolipid biomolecule responsible for 
the modulation of several functions in muscle progenitor cells varying from the differentiation of 
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myoblasts to the motility and division of satellite cells [142,143]. Danieli-Betto et al. studied the 
in vivo activity of S1P in skeletal muscle repair through injecting a 50 µM concentration of S1P 
into the damaged soleus muscle of rats and mice [144]. A significant increase in the cross-sectional 
area of the myofibers and the expression of MyoD and myogenin were observed in the treated 
muscle tissues [145]. Retinoic acid (RA), a derivative of vitamin A, was studied to understand 
their ability to differentiate stem cells into a myogenic lineage. Kennedy et al. treated P19 and 
mouse embryonic stem cells with RA. [146,147] Significant increase in the expression of MyoD, 
myogenin, Meox1, and Pax3 was observed in the treated embryonic stem cells, implying the 
potential of RA as a therapeutic option in skeletal muscle regeneration. Lee et al. used a 
combination approach to screen the skeletal muscle regeneration potential of a range of small 
molecules [148,149]. Two small molecules, skeletal muscle inducer 1 and 2 (SMI 1 and 2), has 
been identified due to their ability to enhance Pax3 expression through the upregulation of the Wnt 
and suppression of the Shh and Smad 2/3 signaling pathways.  
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Figure 6. Schematic representation of the growth factor contributes to the three stages of muscle 
regeneration. Adapted from Ref 69 with permission from Elsevier 
 22 
 
1.6 Biomaterial strategy for skeletal muscle regeneration 
A biomaterial-based strategy has progressed tremendously over the past few decades. An ultimate 
biomaterial needs to be biocompatible, biocompatible, has appropriate mechanical stability, long-
term in vivo functionality as well as to provide a conductive structure for cellular proliferation and 
differentiation[150][2]. 
A combination of both biomaterials and cells can potentially improve the therapeutic effects of 
cells for muscle regeneration[2].  
1.6.1 Electrospun nanofiber matrices 
It is highly desirable to engineer matrices that mimic the natural extracellular matrix.  
Electrospun nanofibrous matrices are beneficial because of their similarity to natural muscle 
fibers[151]. For example, Choi et al. used aligned co-electrospun poly(e-caprolactone) PCL and 
collagen nanofibers to evaluate its potential for skeletal muscle regeneration. The study showed 
the ability of matrices to support alignment and myotube formation of skeletal muscle cells 
(hSkMCs), implying its potential substrate to treat patients with large muscle losses[152]. This 
was further demonstrated by Aviss et al. using aligned PLGA nanofiber matrices seeded with 
C2C12 murine myoblasts. The myoblasts not only showed aligned morphology but also had a 
significantly higher expression of muscle differentiation markers such as fast myosin heavy 
chain compared with randomly oriented fibers[153]. In addition to substrate alignment, electrical 
cues have also shown to promote myotube formation. Electrically conductive random and align 
matrices were prepared by adding different weight percentage of polyaniline (PANI) into poly 
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(ε-caprolactone) (PCL). The study showed that substrate alignment along with electrical 
stimulation could favorably affect skeletal muscle regeneration[154][109].  
1.6.2 Hydrogels 
Hydrogels are prepared from both natural and synthetic polymers with high water content[155]. 
They have been extensively used in biomedical field[67][156].   
Rossi et al. used in situ photo-cross-linkable hyaluronan-based hydrogel to deliver satellite 
cells(SCs) or muscle progenitor cells (MPCs to treat partially ablated tibialis anterior (TA) mice. 
It showed a significant improvement when the injured tibialis was treated with freshly isolated 
satellite cells encapsulated in a hydrogel. Alginates cannot specifically interact with mammalian 
cells. Rowley et al. studied the effect of hydrogel chemistry. Used alginates from different 
monomeric ratio to covalently bond with RGD-containing cell adhesion ligands. The study showed 
a significant impact of alginate monomeric rate or the density of RGD ligands attached at the 
surface of a substrate on myoblast proliferation and differentiation[150].  
Using alginate matrix, Borselli et al. showed that transplanted myoblasts combined with localized 
delivery of VEGF and IGF-1 could enhance muscle regeneration and angiogenesis[157]. Nichol 
et al. demonstrated that gelatin methacrylate (GelMA) was useful in creating cell-responsive 
microtissues, such as endothelialized microvasculature[158]. The hydration and mechanical 
properties of GelMA can be tuned via degree and polymer concentration so it will be suitable based 
on different applications[158]. Another study investigated the role biomaterial can play in 
providing skeletal muscle with mechanical competence matrix. The matrix was prepared by using 
different protein type (collagen I/fibrin/Matrigel) encapsulated in neonatal rat skeletal muscle cells 
to form bundles. The result ended in an increase in contractile force derived mainly from cell-
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matrix interactions. In summary, the biomaterial can play a crucial role in modulating cellular 
response for effective skeletal muscle regeneration[159][160]. 
1.6.3 Patterned matrices 
In addition to types of material, cell behavior can also be altered via substrate surface 
features[161]. Patterning is a favorite technique to modify biomaterial surface properties.  It 
generally involves the use of an elastomeric master such as PDMS, which is easy to mold or 
emboss and can be used directly as a substrate for biomedical applications [5].  A unique study 
by Yang et al. has shown that muscle-derived cells cultured on gelatin-coated nanopatterned 
PLGA substrates showed enhanced myogenic contribution in vivo compared to cells grown on 
flat PLGA after four weeks of transplantation[162]. The group further demonstrated that by 
combining electrical and topographical cues, nanopatterned electroconductive substrates created 
by capillary force lithography could mimic highly aligned collagen bundles from the 
extracellular matrix of skeletal muscle tissue. The combination of both topographical and 
electrical cues can enhance myogenic differentiation and maturation[163]. A unique study has 
shown, when they cultured muscle-derived cells on gelatin-coated nanopatterned PLGA 
substrates and transplanted into quadriceps muscles of mdx mice, those nanopatterned cell 
patches enhanced myogenic contribution in vivo compared to patches generated from flat PLGA 
after four weeks of transplantation[162]. Besides that, many groups have found other influencing 
factors such as groove depth or width of imprinted submicron and different surface materials, 
such as polystyrene[164], agarose[165] as well as methacrylate gelatin[166]. For example, Yang 
et al. used electron beam deposition (FIG.2) to achieve a thin layer of either gold or titanium on 
nanopatterned substrates to create electroconductive substrates with thin layers of either gold or 
alumina. It is found that biomimetic nanotopography combined with these coatings promotes 
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myogenic differentiation and maturation[163]. Together, they all play an essential role in the 
formation of functional myotubes in vitro[167],[168]. 
 
Figure 7. A schematic illustration of the fabrication of A) unpatterned and patterned PUA 
substrates and B) electron beam evaporation deposition of Au and Ti onto PUA substrates111. 
Adapted from Ref [163] with permission from Elsevier. 
1.6.4 Decellularized tissues 
Biologic matrices that are composed of extracellular matrix (ECM) have been used to both 
reinforce or replace damaged tissues in clinical applications[169]. Decellularized tissues can 
maintain their ECM structure as well as their vascular network and have mechanical properties 
resembling native tissue[2].In a study done by Wolf et al., decellularized skeletal muscle ECM 
matrix was shown to provide bioactive compounds such as growth factors, glycosaminoglycans, 
and basement membrane structural proteins that are typically missing from non-muscle ECM 
derived from the small intestine (SIS). The decellularized skeletal muscle ECM has shown to 
support myogenic cells proliferation in vitro. In vivo implantation in a rat abdominal wall injury 
model showed constructive remodeling response along with matrix degradation, even though it 
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showed no statistical difference in remodeling outcome compared with SIS induced ECM[170]. 
Another study by Ward et al. tested the hypothesis that functional muscle efficacy can be retained 
by using a lesser amount of autologous muscle grafts can be volumetrically expanded by using a 
collagen hydrogel. The study showed that even approximately around 50% of the minced graft 
(but not 75%) suspended in a collagen hydrogel, muscle functionality is similar to those of the 
100% minced graft repair. More studies are required to identify optimal carrier materials for 
expansion efficient regeneration[171].  
Valentin et al. tested four types of grafts, porcine small intestinal submucosa (SIS)-ECM, 
carbodiimide-crosslinked porcine SIS-ECM, autologous tissue as well as polypropylene mesh in 
the rat injury model. The graft (1.5 cm × 1.5 cm) is placed on the defect in the ventral lateral 
abdominal wall musculature (Fig.3). Among the four matrices, both biologic matrices composed 
of non-crosslinked SIS and an autologous tissue graft supported functional skeletal muscle 
reconstruction. The regenerated tissue didn’t mimic native tissue but abundant vascularization and 
innervation along with the presence of types I and II muscle fibers in this regenerated muscle[169].  
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Top: the musculoskeletal defect was created by excising the external and internal oblique layers 
of the abdominal wall, leaving the transversal fascia intact. Middle: the test article was implanted 
in the defect site and secured with Prolene sutures at each of the four corners. Bottom: twenty-six 
weeks post-implantation, a flap of tissue was created which contained the site of test article 
placement, identified by the preplaced Prolene sutures. The tissue flap maintained the integrity of 
the muscular arteries and the thoracic spinal nerve branches that supplied the site of tissue 
remodeling. The dense connective tissue at the insertion site at the linea alba was connected to the 
force transducer with silk suture and positioned such that the direction of the contractile function 
testing was aligned parallel to the rib origin. Platinum electrodes were placed across the flap 
proximal and distal to the matrix placement site[169]. Adapted from Ref [169] with permission 
from Elsevier. 
The creation of very first tissue-engineered muscle repair (TEMR) construct showed a significant 
improvement in enhancing myotube numbers as well as functional improvement by two months 
of implantation in a murine latissimus dorsi (LD) muscle with a surgically created VML 
injury[172][173]. In short, acellular bladder matrix (BAM) was used as a matrix to culture muscle-
Figure 8. Representative image of tissue flap 
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derived cells (MDSc) for ten days allowing for cell growth and differentiation in media, and then 
preconditioned in a bioreactor with a 10% uniaxial mechanical as described[172]. Subsequently, 
another study investigated the role of preconditioning MDSc with the uniaxial mechanical strain 
on decellularized ECM with TEMR-positive responders. The study demonstrated combination 
approach significantly increase functional recovery in skeletal muscle compared with construct 
alone in VML injury. The study demonstrated the potentially greater regenerative capacity of 
therapies that include the stem or progenitor cells in addition to a matrix[174]. 
1.6.5 Electrically conductive materials 
Electrically conductive biomaterials are considered as one of the most promising new 
generations of materials that can provide direct delivery of electrical, electrochemical or 
electromechanical stimulation from a substrate to cells[86][175].W ith the development of 
biocompatible electrically conducting materials, several biomedical applications have been 
identified[175][176][71]. Polypyrrole (PPy)[177][89][101] polyaniline (PANI) 89[106], 
polythiophene and their derivatives[112][178] have been tested in bone, neural or skin 
regeneration. For example, Gilmore studied the potential benefits of modified polypyrrole on 
skeletal muscle growth and differentiation. Briefly, polypyrrole was doped with significant 
components of the extracellular matrix such as hyaluronic acid (HA) and chondroitin sulfate A 
(CS) as well as non-biological active molecules such as a dodecyl benzene sulphonic acid 
(DBS), and para-toluene sulphonic acid (pTS)). The doped polymers supported myoblast 
differentiation and myofiber formation to some extent. Besides, different polymer dopant 
differentially affected various stages in skeletal muscle myogenesis. It was found that physical 
properties of the films such as PPy/ HA, PPy/pTS were better suited to facilitating different 
stages in skeletal muscle myogenesis[104]. 
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As mentioned in 4.1, in another study, Jun and Chen et al. both showed improved myoblast 
differentiation when cultured on PANI in combination with poly(L-lactide-co-ε-caprolactone) 
(PLCL) electrospun fibers[154][109].The presence of conducting polymer PANI was found to 
have a significantly increased myotube maturity as well as increased myogenic genes such as 
myogenin, troponin T, and MHC[154][109].  
Ahadian et al. incorporated different concentrations of multi-walled carbon nanotubes (MWNTs) 
into gelatin fibers. It showed improved mechanical properties demonstrated by an increase in 
Young's modulus in the presence of MWNTs from (509 ± 37 kPa to 1077 ± 266 kPa and 1170 ± 
168 kPa for gelatin nanofibers containing 0 mg/ml, 0.5 mg/ml, and 5 mg/ml MWNTs), 
respectively. Increased myotube formation and maturation were observed with increased matrix 
stiffness due to increased mechanotransduction in these substrates[179]. Patel et al. used an acid 
catalyzed sol-gel process to produce silica coating on the CNT-grafted hierarchical substrates.  
The generated carbon nanotube (CNT) carpets were deposited on both interconnected 
microporous carbon foams as well as aligned carbon fiber mats. The result showed that the foam 
structure did not support myotube formation whereas, on aligned carbon mats, myocytes fuse 
into multinucleated myotubes supporting hypothesis. This indicated that specific areas of the 
nanostructure could provide surface roughness and wettability that can correctly facilitate 
myoblast adhesion, growth and differentiation into myocytes[180].  
1.7 External stimulation to enhance muscle regeneration 
Biophysical stimulations such as mechanical and electrical forces play an essential role in 
modulating muscle cell growth and differentiation[181][182].  
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1.7.1 Mechanical stimulation of myoblast differentiation 
Mechanical stimulation can potentially be an efficient approach for muscle regeneration[1].  
Du et al. demonstrated the unique advantage of in vitro preconditioning protocol on primary 
human muscle cell-matrix construct using appropriate mechanical force[183]. Those constructs 
were subject to cyclic strain inside a computer-controlled bioreactor system. It was discovered 
that those retrieved constructs generated tetanic and twitch contractile responses with a specific 
force of 1% and 10%, unlike the native tissue constructs[183]. 
Vandenburgh et al. used a cell stimulator device to dynamically stretch embryonic skeletal 
muscle cells where they maintain the cells in a horizontal position during mechanical stretching 
of up to 400% in substratum length[184]. The study showed the following advantages such as 1. 
The ability for myoblasts fuses into robust and abundant arrays of myotubes which are 2 to 4 
times longer than those myotubes grown under static culture conditions. 2. There is an increase 
in cell proliferation and better orientation because of prestretching the collagen-coated 
substratum before cell plating[184]. 
This was further demonstrated by Cezar et al. using biphasic ferro gels capable of substantial, 
fatigue-resistant deformations to treat a severe injury of C57BL6/J mouse anterior muscle. As 
shown in fig 4 The biphasic ferro gel stimulated directly to the tissue when the pressure cuff 
externally compresses muscle through the skin. The stimulation led to uniform cyclic 
compressions of the flesh on the injured site. Importantly, because of its superior properties, it 
was used to mechanically stimulate and regenerate a severally injured muscle construct without 
the addition of cell therapies or growth factors. The study showed the feasibility of using a 
biologic free matrix that could significantly enhance muscle regeneration[185]. 
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Figure 9. Biphasic ferrogels and pressure cuffs generate cyclic mechanical compressions. 
 (A) Experimental design showing injury, implant, and stimulation profile. (B) Schematic of 
biphasic ferrogel implant in mouse hind limb depicting the orientation of ferrogel relative to the 
skin, muscle tissue, and magnet (Left). Pressure profile of biphasic ferrogel undergoing repeated 
magnetic stimulations (Right). (C) Schematic of pressure cuff on mouse hind limb depicting the 
orientation of balloon and polycarbonate cuff relative to skin and muscle tissue (Left). Pressure 
profile of balloon cuff undergoing repeated inflations and deflations (Right). Adapted from Ref 
[185] with permission from Elsevier. Ultrasound has also been used as a physical force to 
enhance skeletal muscle regeneration[186]. The EPI® technique is an ultrasound-guided 
technique that can generate a galvanic current transmitted through an acupuncture needle, 
localized lysis towards degenerated tissue[186]. Abet et al. used EPI technique to treat tendon 
muscle lesions in a rat model and observed a significant increase in anti-inflammatory proteins 
(PPAR-γ) as well as VEGF and VEGF-R1 expression. Therefore, it enhances the treatment of 
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muscle injuries[1].All in all, these studies indicate the potential advantages of mechanical 
stimulation to enhance muscle regeneration. 
1.7.2 Electrical stimulation of myoblast differentiation 
In vivo, electrical signal play an essential role in the development, function, and repair of tissue 
and organ [187–189]. Various groups, therefore, investigated electrical stimulation as an 
alternative approach to enhance cellular functions [189]. Overall the ability to improve myotube 
formation and maturity has been demonstrated upon electrical stimulation [190,191].  
Nedachi et al. demonstrated robust, evident contraction activities of C2C12 when they were 
subjected to electrical stimulation (40 V/60 mm, 2 ms, 1 Hz) [190]. The study showed the 
efficacy of electrical stimulation on cells to produce contraction-inducible myokines have could 
favorably modulate metabolic, immune responses and angiogenesis (ES) [191]. Also, other 
studies also reported the ability of electrical stimulation to support muscle cells elongation and 
secretion of bioactive factors such as insulin growth factor-1, in skeletal muscle cells [192,193]. 
Langelaan et al. compared the efficacy of C2C12 cell with primary cell culture under electrical 
stimulation through utilizing a collagen type I/Matrigel™ hydrogel. Under electrical stimulation, 
both 2D and 3D culture witnessed accelerated sarcomere assembly formation. Also, primary cell 
source was preferred as they were more susceptible to the electrical stimulus [194].  
Pedrotty et al. evaluated the effect of electrical current flux on the mitogenic activity of skeletal 
muscle-derived cells in vitro. The cells were seeded on 3-D polyglycolic acid mesh scaffolds and 
were subjected to cardiac-like electrical current fluxes treatment, or using culture condition 
media obtained from mature cardiomyocytes. The study showed that both electrical stimulation 
and cardiac-derived soluble factors could stimulate cell proliferation [195]. 
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Burch et al. compared gene expression in electrically stimulated muscle cell culture with non-
electrically simulated muscle cells. The electrically stimulated C2C12 mouse muscle cells 
showed qualitative transcriptional adaptations similar to those in trained muscle, but muscle gene 
expression differed from those with acute effects of exercise. It will be useful for the study of the 
molecular mechanisms that regulate exercise adaptation in muscle [196]. Furthermore, Trumble 
et al. have shown that long-term stimulation of rabbit muscle could change muscle fiber types 
and remodel extracellular matrix indicated by the presence of collagen type I and fibrillin [197]. 
Besides, the ability of chronic low-frequency stimulation to induce the formation of slow muscle 
fibers and enhance glucose uptake in skeletal muscle has also been demonstrated [178,198]. 
1.8 Volumetric Muscle Loss(VML) 
Although skeletal muscle has its intrinsic ability to regenerate, massive defects such as 
volumetric muscle loss (VML) cannot be regenerated[199].  
In a cohort of battlefield-injured soldiers, muscle conditions were found to take up more than 
65% of the disability. Furthermore, 92% of the muscle conditions were identified as VML, 
addressing this means a significant change in orthopedic care12[200]. 
The current standard approach for volumetric muscle loss is to use functional free muscle 
transfer and advanced bracing[201]. Although it looks promising, the procedure is very 
complicated and successful outcome of the surgery depends on the surgical team. Moreover, the 
results of usage of free muscle transfer may not be viable in patients with combat extremity 
injuries[201]. Advances in the use of tissue engineering matrices and stem cells suggest a 
promising solution. It is exciting to imagine that a biomaterial matrix that can be surgically 
implanted at the site of VML, encouraging local muscle regeneration and improving function in 
both animals and humans[202]. 
 34 
People have been exploring matrices utilized in different animals models[199]. Tissue 
engineering strategies discussed in the last chapter that use different types of matrices with or 
without stem or progenitor cell source are under development for the treatment of trauma such as 
volumetric muscle loss [203]. Developing an appropriate animal model to test these approaches 
is also important. 
To mimic volumetric muscle loss, in animal surgeries, the creation of a VML is achieved using 
aseptic technique. In a murine model, The VML injury model was created by surgically 
removing around 50% of the lattissimus dorsi (LD) muscle area in anesthetized nu/nu mice[172]. 
Briefly, after a longitudinal incision along the midline of the back, trapezius muscle that covers 
the LD muscle was lifted. The medial half of the muscle was removed indicated by suture 
markers using a scissor[172]. In a rat model, defect dimension ten mm*7mm* 3mm were first 
labeled and removed using a scalpel from the medial and lateral margins of the muscle[204]. In 
general, a surgical defect was created in the middle third of the TA muscle and a significant 
portion of the estimated TA muscle weight will be removed[202–205]. 
Corona et al. used three different bladders acellular matrix (BAM) collagen matrices seeded with 
muscle-derived cells (MDCs) section 4.2 to create TEMR construct in a mouse model. Based on 
the histological and molecular results, those TEMR constructs helped promote muscle 
regeneration at different rates and magnitudes.  Functional recovery via regeneration of 
functional muscle fibers occurred either at the interface of the construct and the native tissue or 
within the BAM matrix independent of the native tissue[206]. 
Corona also evaluated the efficacy of syngeneic muscle-derived ECM (mECM) seeded with 
bone marrow-derived mesenchymal stem cells in treating rat tibialis anterior (TA) muscle VML 
injury. The study showed the feasibility to recover one-third of the first functional deficit two 
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months post-surgery using mECMs. Moreover, the presence of mECM decreased further muscle 
damage in the remaining muscle sees (Fig.5)[203]. The study pointed out that with the help of 
these new biological ECM matrices, prolonged overload of injury muscle is prevented in this 
case[203].  
 
 
 
Figure 10. The contribution of donor-derived myogenic cells to de novo fiber regeneration after 
VML injury. TA muscle minced grafts derived from donor GFP-Lewis rats were transplanted to 
the site of VML injury at a 100% tissue replacement. 
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 (A) Longitudinal (scale bar = 1.0 cm) and (B–E) cross-sections (scale bars = 50 lm) from the 
remaining muscle mass (B, C) and defect area (D, E) were probed for sarcomeric myosin and 
GFP co-localization. TA, tibialis anterior; VML, volumetric muscle loss[171].  
There are also other research groups suggesting such that SIS-ECM may not be effective in 
promoting muscle regeneration[207] This may be related to differences in matrix fabrication 
process as well as a selection of surgical models. (TA muscle vs. lateral gastrocnemius 
employed)[208]. Adapted from Ref [208] with permission from Elsevier. 
The efficacy of ECM based matrix to treat VML injury was demonstrated by Badylak et al. using 
a canine model.  The study showed that an ECM-based matrix helped promote functional 
restoration of the distal gastrocnemius musculotendinous junction after complete resection of the 
tissue[207].  
In another study with canine injury models, the study was carried out using non-crosslinked 
ECM derived from porcine small intestinal submucosa(SIS). Although the initial modeling 
process showed promising results at later stages showed fibrosis, dense collagenous tissue and a 
small portion of nonfunctional muscle in a complex quadriceps muscle injury in dogs 
models[208]. Further study is required to understand the efficacy of these biological matrices in 
treating VML[208]. 
So far, ECM matrices have been on the preclinical trial. Sicari et al. evaluated ECM matrices 
using a mouse VML model and showed the ability of the matrix in supporting skeletal muscle 
formation as well as innervation. This was followed by a clinical study using this matrix in five 
patients with VML. Six months post-ECM all patients showed signs of new muscle formation 
and blood implantation at the site of implantation. Three of the five patients showed 20% or 
more significant improvement in limb strength during physical therapy. The two patients without 
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functional changes did report improvements in nonfunctional tasks, such as balance, as well as 
an increase in the quality of life. Because of the widespread availability and known safety of 
cell-free ECM-based materials, they hold promise as a candidate material in treating VML[202].  
1.9 Muscle atrophy in rotator cuff injury 
Rotator cuff tear is one of the most frequently seen orthopedic conditions, and repair of rotator 
cuff tears is a common procedure[209]. As the rotator cuff ages, it becomes nonresistant to 
degenerative tears. It was estimated that 40% of those aged over 60 are bothered with rotator cuff 
issues, and repair failure rate ranging from 20% to 70% remains a significant clinical 
challenge[210]. 
Tears that are higher than 4 cm are called large RCTs. They have been found to cause atrophy as 
well as fatty infiltration in supraspinatus and infraspinatus muscle[211]. In Cofield's study, 
roughly 94% of patients with large RCT experienced atrophy and fatty infiltration and resulted in 
a relatively poorer recovery outcome in comparison with those that do not have atrophy and fatty 
infiltration. The poor issues of large tears are due to the inelasticity and reduced function of the 
muscle-tendon unit and can lead to shoulder dysfunction [212][213]. Upon rotator cuff tear, the 
study showed an increase in symptoms and tore size over time[213]. 
Gladstone et al. demonstrated poorer skeletal muscle quality, especially in the region of 
infraspinatus, negatively affects the outcome. Also, it has been shown a successful rotator repair 
can significantly decrease the likelihood of fatty infiltration and muscle atrophy[214].  
All in all, chronic RCTs can lead to pain and suffer the patients, poor shoulder function, 
pain[211]. So far current studies have been having been focused on developing improved repair 
techniques[215], using biologic factors[216] or biomaterials[217][218] to enhance tendon to 
bone healing. Repair with aligned PCL electrospun matrix augmentation was compared with 
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control with no matrices. The results showed that with implantation of matrices, there is better 
cellular infiltration. No adverse effect of surgical implantation was observed[219]. Thangarajah 
et al. used demineralized bone matrix (DBM) derived from cortical bone to treat female Wistar 
rats with three weeks' delayed repair. The study result showed a shorter gap between tendon and 
bone. Less disorganized structure and less abnormal collagen fiber were observed compared with 
commercially available GraftJacket. However, the use of DBM matrices didn't show 
improvement of enthesis healing compared with nonaugmented controls or GraftJacket [218]. 
Zheng et al. used 3D aligned collagen/silk matrix (ACS) to treat rabbit tendon tear. Both 
improvements of better cellular infiltration and enhanced tenogenic differentiation were 
observed[220]. 
There are no current biomaterial strategies addressing muscle atrophy issue in rotator cuff injury, 
but the condition exists.  Research-wise, people have been using animal models such as rats, 
rabbits or sheep to determine the temporal changes that take place in the region of supraspinatus 
muscle after tendon detachment[221][220]. It was hypothesized that tendon detachment would 
lead to lack of load thus would cause significant muscle weight loss as well as a conversion of 
the muscle types. Using a rat rotator cuff model Barton et al. observed a consistent fiber shift 
throughout the study, rapid loss of muscle volume as well as scar tissue formation in the muscle 
bed[222]. 
In a study done in a rat rotator cuff model by Davis et al. regarding to both acute and chronic 
rotator cuff repair, they stated that at the time of chronically torn rotator cuff repair, failure to 
successful  repair the tendon will lead to continuous progression of fatty degeneration, which is 
commonly seen in some patients that received rotator cuff repair[223].  
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Rowshan et al. used a rabbit denervation rotator cuff injury model and found that it will worsen 
muscle atrophy and fatty degeneration. Six weeks after injury, muscular changes in the complete 
tear group or with the nerve transection group had similar but significant decreases in wet mass 
and increases in fat content relative to the control groups[224].  
In larger animal models, signs of muscle atrophy and fatty infiltration after injury are more 
visible. Luan et al. using a sheep rotator cuff model also demonstrate the occurrence of muscle 
atrophy and fatty infiltration six months after initial surgery. The repair group still had increased 
expression of muscle atrophy, fatty infiltration, and fibrosis-related genes. The study 
demonstrates the clinical importance of addressing fatty infiltration and fibrosis upon rotator cuff 
tear[225]. 
1.10 Concluding remarks 
In this review, we first discussed cell-based strategies which are conventional but very useful to 
this day. Then we talked the use of small molecules and drugs in muscle regenerative 
engineering. Since biomaterials play an increasingly significant role in regenerative muscle 
tissue engineering, detailed discussions were given on different types of materials, how materials 
interact with cells and how they modulate physical, chemical or mechanical behaviors of cells 
that can alternate cellular activities. It is evident that the potentials of biomaterials are not only 
vehicles that deliver cells, drugs or small molecules, but also at as tools that control cellular 
functions, therefore enhancing the endogenous muscle regeneration response. It was also 
discovered that muscle contractility and functionality could be improved by physical forces such 
as mechanical and electrical stimulation. Furthermore, this article has been focusing on the 
translational side of biomaterials. Many research groups have been started testing their 
biomaterials on animal's models or even in clinical trial. It is fascinating as the ultimate goal is to 
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transfer all these biomaterials "from bench to bedside." To do this, a deeper understanding and 
discoveries need to made in advanced materials science, stem cell area, physical forces, 
developmental biology, and clinical translation. It is not unusual nowadays to see material 
scientists, clinicians as well as biologists working together to make biomaterials and cell 
therapies translational. 
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CHAPTER 2. PRELIMINARY STUDIES AND SPECIFIC AIMS 
2.1 Preliminary Results 
 
 
 
 
The substrate material was electrospun using optimized parameters of 15 % (w/v) PCL solution 
in ethanol and methylene chloride (15:85 ratio) with a 2.5 mL/min flow rate, and 1 kV/cm-1 
potential at ambient temperature and humidity to obtain bead-free nanofibers. 
Conductive matrix fabrication:  
2mg/ml dopamine was applied to the surface for 24 hours at pH 8.5 to polymerize onto the 
surface of PCL fiber mats to form a polydopamine coating2. The modified DOPA-PCL surfaces 
were washed, dried, and subsequently coated with 1% PEDOT: PSS, 10% PEDOT: PSS, 33% 
PEDOT: PSS, and 100% PEDOT: PSS solution, where the 100% solution indicates a PEDOT: 
PSS 1.3wt% dispersion in H2O and 33%, 10%, 1% are further diluted with PBS.  The dried 
matrices were treated with mild acetic acid pH 2 to enhance its conductivity[226]. 
 
(a) 
Figure 11.Schematic illustration of the conducting polymer coated matrices228 
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(b) 
 
Figure 12. XPS analysis on (a) Dopamine polymerized PCL matrices. (b) PEDOT: PSS coated 
dopamine polymerized PCL matrices 
Fig. 2(a).  It shows that dopamine treatment was successful by the presence of nitrogen on the 
surface of the composite nanofibers as confirmed by XPS, where the N 1s peak was observed at 
399.872 eV for the dopamine polymerized PCL matrices.  According to the literature, there was 
no nitrogen peak being found in the PCL samples[154,227].  (b) Both sulfer in PSS and sulfer in 
PEDOT were shown.  The percentage are 52% against 48%, which indicated that acid treatment 
did take away excessive PSS[226], as the original PEDOT:PSS ratio was 1:2.5. XPS analysis 
 
 43 
confirmed that poly(dopamine) eposition on the PCL matrices was successful,which was 
consistent with previous reported literature[228]. The additon of PEDOT:PSS was stable as both 
representative peaks were shown. Besides, acid treamtent took away excessive PSS as the final 
PEDOT:PSS ratio was almost 1:1 compared to intial 1:2.5.  We have successfully coated 
PEDOT:PSS onto surface modified PCL matrix. This matrix fabrication method was 
straightforward yet effecitve. It provided an alternative approach as coducting polymers are 
conventionally electrochemically deposited on hard surfaces and the fabrication process invovled 
several steps[64,229]. 
 
 
 
Figure 13.Day 1 C2C12 cells live dead (100% indicates 100%PEDOT: PSS, 33% indicates 33% 
PEDOT: PSS etc) 
 
 
After seeding 80K C2C12 myoblasts on each treatment group of the nanofiber matrices, cell 
viability was qualitatively assessed using a Live/Dead Cell Viability assay kit. As shown in (Fig. 
3), between the six groups, after 1 day, the vast majority of the cells were viable, suggesting that 
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the developed matrices were cytocompatible and can provide topographical cues to for cell 
growth. 
 
Figure 14.C2C12 cells three-day proliferation study 
80K C2C12 cells were seeded on matrices on each of the 6 test groups. From the proliferation 
study on day 3 on (Fig. 4), Statistically, PEDOT:PSS of high concentration groups (33% and 100%) 
showed similar effect on cell viability compared to the control group. Interestingly, PEDOT:PSS 
of a low and medium concentration(1% and 10%) showed stimulatory effect on C2C12 growth 
compared to the control groups as there was statistically significance between these groups. This 
results showed that the presence of PEDOT:PSS at optimun concentration may enhance C2C12 
cell growth. It confirmed our hypothesis that conducting polymers may have a positive effect on 
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cell growth, proliferation or even differentiation,which needs more investigation. This platform 
may further be optimized for tissue engineering or bioelectric applications when combined with 
small molecules, growth factors and along with electrical stimulation.  
 
2.2 Overall Objective and Specific Aims  
Around 40% to 45% of the human body’s mass consists of skeletal muscle. Remarkably, skeletal 
muscle has the ability to perform robust self-repair after injury[230][2]. However, when a large 
volume of muscle is lost as a result of trauma or due to chronic disease, the ability of skeletal 
muscle to regenerate is limited[202]. The current therapeutic approach for muscle volumetric 
loss is to transfer and engraft healthy, vascularized, and innervated autologous tissue. Yet, this 
approach does not lead to full recovery of pre-injury muscle strength and functionality, and 
harvesting skeletal muscle can cause donor site morbidity[2]. Here we propose to use 
regenerative engineering as an alternative approach for patients with large volume muscle loss to 
prevent scar tissue formation and for restoration of muscle function in moderate injuries[2]. A 
more clinically viable matrix would satisfy the following attributes: biocompatibility, mechanical 
stability, long term in vivo functionality (electrical conductivity), complete cell residence 
throughout the three-dimensional structure, as well as cues to support and promote the 
proliferation and differentiation of cells throughout the three dimensional structure of the matrix. 
Our goal in this study is to modulate the cellular physical microenvironments to allow the 
application of controlled electrical impulses via electroconductive nanofiber matrices to generate 
a more robust and functional muscle construct for muscle regeneration. The development of this 
system may have a significant clinical impact, where muscle atrophy and fatty infiltration 
prevent healing of rotator cuff injuries[213]. In order to determine the success of these methods 
the research has been organized into the following specific aims: 
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2.2.1 Specific Aim 1 
Specific Aim 1: Evaluate the utility of electroconductive nanofiber matrices with tunable 
conductivity. 
Nanofiber matrices will be fabricated by incorporating a conducting polymer, 
poly(3,4ethylenedioxythiophene): poly(styrenesulfonate)  (PEDOT:PSS), onto the surface 
modified electrospun nanofiber metrics. Electrospinning of random and aligned fibers will be 
made. It is hypothesized that the created polymer is biocompatible, electroconductive, and 
mechanically competent. Scanning Electron Microscopy (SEM) will be used for characterization 
of fiber diameter and orientation. Dopamine polymerization will be applied onto poly(ε-
carprolactone) PCL surface. The surface chemistry will be tested using XPS. Different 
concentrations of PEDOT: PSS solution will then be coated onto the poly(ε-carprolactone) PCL 
nanofibrous matrices. Biocompatibility of matrices coated with different concentration of 
PEDOT: PSS will be studied using a cell viability assay as well as live/dead staining.  The 
physicochemical and biological properties of the matrix will be optimized and used for specific 
aim 2.  
Challenges, Pitfalls, and Alternative Strategies: From the preliminary results, we do not 
anticipate issues in fabricating the matrix with appropriate physicochemical and biological 
properties. However, maintaining the efficient electrical conductivity of the matrix throughout 
surgery may be challenging due to matrix degradation and complex biological processes. As an 
alternative, we propose either to make coelectrospinning of conducting polymer with PCL 
matrices, or we can plasma treat the PCL matrices to make them more hydrophilic and 
susceptible to coating of a conducting polymer thereby providing long-term electrical 
conductivity. 
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2.2.2 Specific Aim 2 
Specific Aim 2a: Determining the effect of topographical cues to enhance myoblast 
differentiation of C2C12, a myoblast cell line, and mouse muscle stem cells (satellite cells) in 
vitro.  
It is hypothesized that aligned electrospun nanofibers could provide surface functionality by 
mimicking parallel alignment of the multinucleated fibers of muscle tissue. PCL matrices with 
random orientation and aligned orientation will be compared and evaluated. Phenotypic 
progression will be assessed through RT-PCR (Real-Time Quantitative Reverse Transcription 
PCR) to see if there is upregulation of myogenic regulatory factors. Myotube formation will be 
assessed through immunohistochemistry, cells will be stained for sarcomere-myosin heavy chain 
(green) and nuclei(blue). It is expected that compared to random orientation matrices, the aligned 
matrices will facilitate differentiation of C2C12 cells. Studies will be carried out first in C2C12, 
a myoblast cell line, and then in mouse muscle stem cells (satellite cells). 
Challenges, Pitfalls, and Alternative Strategies: Based on preliminary cell proliferation study, 
cell number was higher on aligned electrospun nanofiber matrices than random electrospun 
nanofiber matrices at day 7. However, pure PCL electrospun nanofibers may be hydrophobic 
which would decrease cell attachment and proliferation. As an alternative, we propose to 
compare the effect of topographical cues on dopamine modified electrospun nanofibers, which 
are hydrophilic and support cell growth and differentiation.  
Specific Aim 2b: Evaluate the ability of electroconductive matrices to promote migration, 
proliferation, and differentiation of both C2C12, a myoblast cell line, and mouse muscle stem 
cells (satellite cells) in vitro.  
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In addition to specific aim 2a, it is hypothesized that the addition of electrical cues will enhance 
cell proliferation and myogenic differentiation. Myogenic differentiation will be assessed 
through RT-PCR and immunohistochemistry. Matrices with random orientation and aligned 
orientation coated with conducting polymer will be compared and evaluated. It is expected that 
conducting polymer-coated matrices will facilitate myoblast differentiation compared to control 
matrices. Studies will be carried out first in C2C12, a myoblast cell line, and then in mouse 
muscle stem cells (satellite cells). Based on these experiments, the optimized matrix that yields 
the best overall in vitro performance will be selected for Specific Aim 3. 
Challenges, Pitfalls, and Alternative Strategies: From the preliminary study an upregulation of 
gene expression of C2C12 cells on electroconductive matrices was seen. However, if the 
conducting polymer, with its intrinsic conductivity is not efficient to stimulate muscle 
differentiation, as an alternative we propose to add an electrical field to the cells. It is known that 
electrical signals can modulate cell growth and differentiation by guiding remodeling of the 
cellular microenvironment and by regulating gene expression[231].  Electrically excitable 
C2C12 muscle cells will be seeded in electrically conductive matrices and stimulated with pulsed 
voltage and frequency[231]. 
2.2.3 Specific Aim 3 
Specific Aim 3: Evaluate the biological performance of the optimized novel electroconductive 
matrices in a clinically relevant, well-established rat rotator cuff defect model. 
It is discovered that massive rotator cuff tears have close association with atrophy, fibrosis, and 
fatty infiltration (FI) of the supraspinatus and infraspinatus muscles. Thus it is hypothesized that 
electroconductive matrices seeded with satellite cells will improve functional tendon and muscle 
regeneration[213]. It is also hypothesized that delivery of skeletal muscle satellite cells from the 
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electroconductive matrices will significantly improve tissue regeneration via recruiting 
circulating stem cells, and in turn increase/modify ECM protein synthesis and 
immunomodulation.  
Skeletal muscle satellite cells will be isolated from male rats and seeded on aligned PCL 
electrospun nanofiber substrates as well as PEDOT: PSS coated aligned electrospun nanofiber 
substrates. The aforementioned tissue engineered constructs will then be transplanted to the 
tendon insertion site following an existing protocol. In brief, the subscapularis tendon will be 
exposed through an incision under the clavicle. Spreading of the deltopectoral interval to expose 
the shoulder and coracobrachialis muscle will allow exposure of the subscapularis tendon. Full 
thickness tears of the tendon will be made by complete transection of the subscapularis tendon 
from the bone[232]. To assess engraftment, rats will be euthanized and tissues will be harvested 
at certain time point post-transplantation for analysis. Tendon tissue sections will be imaged and 
quantified using immunohistochemistry. Histology of tissue will also be looked at as an evidence 
of fatty infiltration or regression[232][233].  
Challenges, Pitfalls, and Alternative Strategies: 
There is an established rat rotator cuff model. The PI is a renowned orthopedic surgeon and is 
extensively published in this area. Additionally, personnel who are trained in the surgical 
technique will conduct the surgery, therefore we do not anticipate any problems with surgical 
reconstruction. However, the mechanical characterization of the bone-tendon interface may be 
challenging. As an alternative, we propose to characterize the bone-tendon interface 
histologically. 
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CHAPTER 3: EVALUATE THE UTILITY OF 
ELECTROCONDUCTIVE NANOFIBER MATRICES WITH 
TUNABLE CONDUCTIVITY 
 
3.1 Introduction 
Conducting polymers (CPs) are a novel generation of organic materials first produced in the mid-
1970s[71]. Research on CPs for biomedical applications expanded greatly in the 1980s when it 
was found that conducting polymers were compatible with many biological molecules. 
Numerous applications are found such as neural probes,[64] neural prostheses [65][66]as well as 
controlled release applications.[67][68][69][70][71].Major conductive polymer such as 
polypyrrole (PPy)[72][73] polyaniline (PANi) [74][72]polythiophene [75]and their 
derivatives[76][77][78][79] were developed and their biocompatibility in vitro and in vivo were 
studied. More importantly, they have general properties that are desired for regenerative 
engineering applications including conductivity, reversible oxidation, redox stability, 
biocompatibility, hydrophobicity, three-dimensional geometry and surface topography[80][81]. 
Here in this chapter, I am charactering Poly(3,4-ethylenedioxythiophene) (PEDOT), a 
polythiophene (PTh) derivative, newly emerged in recent decades. It has already being used in 
numerous  biomedical applications such as biosensing and bioengineering applications [234], 
electrical controlled drug release[68], as well as nerve grafts and heart muscle patches[112], it 
will be used in this study for muscle cell and material interface regeneration.  It has captured a 
considerable amount of attention owing to its good electrical, chemical and environmental 
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stability and better conductivity and thermal stability than conventionally studied 
polypyrrole(PPy)[86].  
3.2 Materials and Methods 
PCL, dopamine hydrochloride (average Mw 8000), and poly (3,4-ethylenedioxythiophene)-
polystyrene sulfonate (PEDOT: PSS 1:2.5) were purchased from Sigma-Aldrich.  
3.2.1 Matrix preparation 
In this study, substrate material of random strucutre was electrospun using optimized 
electrospinning parameters of 15 % (w/v) PCL solution in ethanol and methylene chloride (15:85 
ratio) with a 2.5 mL/min flow rate, and 1 kV/cm-1 potential at ambient temperature and humidity 
to obtain bead-free nanofibers. Substrate material of aligned strucute was electrospun using a 
rotating motor setup and was optimized at 6V to produce aligned strucutre. Dopamine (2mg/ml) 
was applied to the surface for 24 hours at pH 8.5 to polymerize onto the surface of the PCL fiber 
mats and form a polydopamine coating[115]. The modified DOPA-PCL surfaces were washed, 
dried, and subsequently coated with 30 µl of 1% PEDOT: PSS, 10% PEDOT: PSS, 33% 
PEDOT: PSS, or 100% PEDOT: PSS solution, where the 100% solution indicates a PEDOT: 
PSS 1.3wt% dispersion in H2O and 33%, 10%, 1% are further diluted with PBS.  The dried 
matrices were treated with mild 13.3% acetic acid, which is pH 2 to enhance its conductivity. 
3.2.2 Characterization of conductive matrices  
The fiber morphology and diameter of all groups were examined by scanning electron 
microscopy (SEM) (FEI Nova NanoSEM 450). Briefly, the fibers were mounted onto sample 
studs and coated with gold using a sputter (Polaron E5100) for 3 minutes. The SEM images were 
analyzed with ImageJ software to determine the average fiber diameter. The average and 
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standard deviation of the fiber diameter were calculated from 50 random measurements per 
image.  
3.2.3 Conductivity testing 
The conductivity of the different concentrations of conductive matrices (1 inch × 1 inch, n=3) 
was measured using the four-point probe technique using a Keithley 6000 picoammeter 
(Keithley; Cleveland, Ohio) at a voltage sweep of 1–10 V by applying a constant current of 2.5 
mA between two alligator clips. The conductivity (σ , S cm −1 ) of the electroconductive 
substrates ( n = 3) was calculated based on the equation: σ = l / (R s S) (where l is the distance 
between reference electrodes, R s is the bulk resistance of the membrane sample derived from an 
impedance analyzer, and S is the cross-sectional area of the sample) as previously reported[235]. 
3.2.4 Surface Wettability Analysis 
The water contact angles of substrates were measured to examine surface wettability in relation 
to topography and surface coating. The surface hydrophobicity of various matrices was 
determined by adding a droplet of deionized water (5 µL) onto a dry sample at room temperature 
and allowing the droplet to equilibrate for 10 s. The water droplet images were captured by a 
charge-coupled device (CCD) camera, and the mean contact angles were then calculated using 
ImageJ software analysis (National Institutes of Health, Bethesda, MD). The surface 
hydrophobicity of the blend films was determined by measurement of the contact angle of water 
using a contact angle and surface tension meter (KSV Instruments Ltd). The contact angle of 
each sample was taken as the average of three measurements at different points on the surface of 
the samples. 
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3.2.5 Statistical Analysis 
All quantitative data were expressed as the mean ± standard deviation. Both one way and two-
way ANOVA tests were used.  The Tukey pairwise comparison test was performed on samples 
to determine significant differences. The assumptions for ANOVA were found to satisfy 
Levine’s test for homogeneity of variance and passed tests for normality. A value of p < 0.05 
was considered statistically significant. 
3.3 Results 
3.3.1 Conducting polymer particle size distribution 
 
 
Figure 15. Particle size distribution 
 
We used PEDOT:PSS 1.3wt% dispersion in H2O (Sigma Aldrich). For proper  
particle size distribution, 1:30 dilution was made to original solution. It showd an average size 
of 384.9 ± 3.8 nm.  
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 3.3.2 Electroconductive nanofiber matrices illustration  
 
 
 
Figure 16.Schematic illustration of the conducting polymer coated matrices and myotube 
formation on those electroactive matrices. 
 
First, we electrospun the substrate material using optimized electrospinning parameters of 15 % 
(w/v) PCL solution in ethanol and methylene chloride (15:85 ratio) with a 2.5 mL/min flow rate, 
and 1 kV/cm-1 potential at ambient temperature and humidity to obtain bead-free nanofibers. 
Then, we used dopamine to polymerize on the surface of the PCL matrices for 24 hours at a pH 
of 8.5. The modified DOPA-PCL surfaces were washed, dried, and subsequently coated with 
different concentrations of PEDOT: PSS. The dried matrices were treated with mild acid to 
enhance its conductivity [226].  
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In the experiment conducted in this report, pure PCL serves as control 1, while dopamine 
(DOPA) coated PCL serves as control 2. 1% means DOPA -PCL matrices were coated with 1% 
PEDOT:PSS , 10% with 10% PEDOT:PSS, 33% with 33% PEDOT:PSS, and 100% with 100% 
PEDOT:PSS. (Note: 100% means use as purchased which is PEDOT:PSS 1.3wt% dispersion in 
H2O. 33%, 10%, 1% are further diluted with PBS solution.)  
3.3.3 SEM analysis 
 
 
 
 
 
 
 
 
From the SEM images in (Figure 2), the topography of pure PCL nanofiber metrics shows a 
smooth surface while dopamine polymerized surface shows some surface roughness without a 
change in its diameter.  The distribution of PEDOT:PSS is relatively uniform. There is an 
increase in PEDOT:PSS particles as the concentration of solution increases.  The differences of 
PCL	
100%	33%	
10%	DOPA	
Figure 17. SEM showing nanotopography preservation and PEDOT distribution (8000x) 
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topographies and confuctivity may affect myoblast morphology and maturation, which will later 
be discussed further. 
3.3.4 Contact angle measurement 
 
 
 
 
(a) Pure PCL                                  (b) Dopamine polymerized PCL 
 
Figure 18. Contact angle analysis for (a) Pure PCL (b) Dopamine polymerized PCL 
Contact angle shows 125.3 0C from untreated PCL to 0 0C of dopamine polymerized matrices. 
From the result, we can know that the dopamine coating is effective in changing hydrophobicity 
while minimize changing fiber morphology (fiber diameter unchanged from SEM analysis). 
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3.3.5 Conductivity measurement 
 
Figure 19. Sheet Resistance of different concentration of PEDOT:PSS coating 
Electrical properties of PEDOT:PSS coated matrices have been studied by repeating sheet 
resistance measurements with a four point probe method.[236] 
Sheet resistance is inversely propotional to condutivity. We observed changes in surface 
electrical conductivity with respect to the different concentraions of conducting polymer (Figure 
3), which is consistent with SEM images in Figure 2. Pure PCL matrices or dopamine coated 
PCL matrices have no detectable electrical conductivity. DOPA-PCL coated with different 
concentrations of PEDOT:PSS demonstrated a wide range of electrical conductivity, with the 
100% group possessing average sheet resistance values of around 5× 104 , 33% around 13× 105, 
and 10%  around 17× 106. The 1% group showed relatively higher and inconsistent resistivity, 
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and thus is not listed on the figure. From the sheet resistivity testing, it can be concluded that 
conductivity is directly correlated to PEDOT:PSS solution concentration.  
3.3.6 In vitro evaluation of electroconductive nanofiber matrices 
In vitro C2C12 cell adhesion and proliferation on electroconductive nanofiber matrices  
 
 
Figure 20. C2C12 Proliferation on PEDOT Coated PCL Nanofibers  
80K C2C12 cells were seeded on matrices on 6 test groups (consistent with live dead study). 
From the proliferation study on day 3, day 7 and day 14, no toxicity was shown among all 
treatment and control groups. PEDOT of higher concentration (33% and 100%) inhibited cell 
proliferation in the first week, then started showing a stimulatory effect on C2C12 growth in 
second week. PEDOT of a low and medium concentration(1% and 10%) showed stimulatory 
effect on C2C12 growth during first week and second week. In general, it is observed that 
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PEDOT of low and medium concentration (1% and 10%) promoted a higher level of cell 
growth than the two control groups. 
 3.3.7 Live dead staining on C2C12 cells 
 
 
 
 
 
 
 
 
 
 
80K C2C12 cells were seeded on matrices on 6 test groups. On day 3, 3 representive images 
were taken for each group and live dead cells were counted.  All six groups showed more than 
90% cell viablity, which indicates mild or even no cytotoxicty.  For the 1% and 10% group, the 
cell density is similar to the two control groups and are relatively higher than the 100% and 33% 
groups.  This suggests that high concentraions of PEDOT:PSS may have an impact on cell 
proliferation but exhibits very mild toxicity.  
100%	 10%	33%	
1%	 DOPA	 PCL	
Figure 21. Live dead on PEDOT Coated PCL Nanofibers Day 3 
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3.4 Discussion 
The demand for alternatives approach to currently available muscle flaps has inspired 
regenerative tissue enginnering field with many carefully designed matrices[2].  Here in this 
chaper, the design goal is to create a conductive matrices with minimun but effcient conductivity. 
The ultimate goal is to modulate the cellular physical microenvironments to allow the application 
of controlled electric impulses via electroconductive nanofiber matrices to generate a more 
robust and functional muscle construct for muscle regeneration. 
Dopamine polymerzation in preliminary data section suggested that this type of method is 
successful. Acid treatment can take away excess PSS thus enhanceing sheet conductivity. It aslo 
changed surface hydrophlicity from 120 °𝐶	 to 0	°𝐶. Dilution of original conducting polymer 
showed uniform partcile size based on particle size distribution graph. SEM images showed that 
higher concentration, more roughness in the surface of nanofibers but it won’t change nanofiber 
surface diameter. Electroconductive nanofiber matrices with tunable conductivity were 
successfully fabricated. Four-point probe conductivity testing substantiated that the conductivity 
could be controlled by modifying the concentration of PEDOT:PSS applied on matrices. The 
100% group possessed an average sheet resistance value of ~5× 104, while the conductivities of 
the 33% and 10% group were 13× 105 and 17× 106, respectively. The preliminary  assessment of 
biocompatibility of the C2C12 cells seeded on the matrix was performed using live/dead assay 
and cell titer blue assay. It has been shown that the presence of PEDOT: PSS in the matrices 
enhanced the muscle cell viability, attachment and proliferation. Analyzing all the experimental 
data from different types of matrices, we concluded that the incorporation of conducting polymer 
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might facilitate muscle cell growth.  The results of in vitro cell viability assays suggested that 
PEDOT:PSS coating exhibited no toxicity.  
Further studies will examine the ability of the this conductive matrices in vitro in regards to its 
proliferation and differtiation properties. All these findings in conjunction with those here will 
assist in the development of an optimized conductive matrix for muscle tissue engineering. 
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Chapter 4. EVALUATE THE ABLILITY Of 
ELECTROCONDUCITVE MATRICES TO PROMOTE 
MIGRATION, PROLIFERATION, AND DIFFERTIATION IN 
VITRO  
4.1 Introduction 
As previously mentioned, a current standard approaches for muscle volumetric loss is to transfer 
and engraft healthy, vascularized, and innervated autologous tissue. However, it comes with a 
host of morbidity issues and there is not total recovery to pre-injury muscle strength and 
functionality[2]. The introduction of regenerative engineering methods can be a potential 
treatment option for patients with a large volume muscle loss. Meanwhile, it is highly desired to 
create a stimulus-responsive biomaterial with easy-to-tailor properties. For example, electrical 
signals are critical physiological stimuli that can be used to  control adhesion and differentiation 
of cell types such as neuron and muscle cells[109]. Nowadays, the use of conducting polymers 
has been more studied in the area of neuron regeneration, biosensors, neural implants, drug 
delivery devices and regenerative engineering matrices[86]. A novel stimuli-responsive 
conducting polymer matrix was already engineered and successfully fabricated in last chapter. In 
this chapter, we are going to assess muscle cell adhesion, proliferation and differentiation on this 
matrices in vitro.  
Our hypothesizes is that aligned electrospun nanofibers could provide surface functionality by 
mimicking parallel alignment of the multinucleated fibers of muscle tissue. Further, it is 
hypothesized that the addition of electrical cues will enhance cell proliferation and myogenic 
differentiation.  
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4.2 Material and Methods 
4.2.1 Electrospinning of aligned matrices 
10 mL of the PCL solution was placed into the syringe in the electrospinner with a 2.5 mL/min 
flow rate, and 20KV at 15 cm distance at ambient temperature and humidity to obtain bead-free 
nanofibers. A rotator was used to produce sheets with aligned nanofibers. After optimization, 6 
V rotator voltage was chosen as optimum voltage for speed to produce consistent aligned 
nanofibers. Fiber diameter ranges from 2um to 5um. It falls the same range as random nanofibers 
fabricated previously.  
4.2.2 Culture of murine skeletal muscle cells C2C12myoblasts(C2C12) 
C2C12myoblasts (CRL-1772) (ATCC, Manassas, VA) were used to study cell proliferation and 
differentiation on fibers. Cells were cultured in DMEM supplemented with 10% FBS and 1% 
penicillin–streptomycin (p/s) under standard culture conditions (37 OC, 5% CO2). For cell 
culture, circular matrices were punched out using 5’ size puncher, approximately 1.9 cm2 and 
sterilized with 70% ethanol and UV for half an hour. Cells were seeded onto the different groups 
at a density of 100K per well or matrix and cultured with growth media for 3 days. To induce 
myotube formation, the media was then replaced with differentiation media (DMEM 
supplemented with 2% horse serum and 1% p/s) and cultured for an additional 5 and 11 days. 
4.2.3 Satellite muscle cell isolations 
We followed a straight forward protocol for skeletal muscle satellite cells isolation using 
FACS.[237] 
It involves 31 steps on how to isolate and characterize satellite cells from mouse hindlimb 
muscles. 
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4.2.4 Live/dead cytotoxicity assay  
Cytotoxicity of the 1% PEDOT: PSS, 10% PEDOT: PSS, 33% PEDOT:PSS, and 100% 
PEDOT:PSS as well as dopamine polymerized PCL and pure PCL matrices were determined 
with the live/dead cytotoxicity assay. CellTracker green and ethidium homodimer-1 (Molecular 
Probes) were added to day three cultures of C2C12 cells on the above-described matrices to 
determine cell viability (green fluorescence) and cell death (red fluorescence) through the use of 
laser scanning confocal microscopy (Leica TCS SP2, Germany). The results represent the mean 
values of three individual samples for each type of matrix.  
4.2.5 Cell proliferation 
For the cell proliferation studies, 80 K cells were seeded on each of the matrices. After 3, 7, and 
14 days of cell culture, the cell proliferation was determined using a MTS assay kit (CellTiter 
96® AQueous One solution, Promega) according to the manufacturers’ instructions  Briefly, 
assays were performed by adding a small amount of the CellTiter 96® AQueous One Solution 
Reagent directly to culture wells at specific intervals, incubating for half an hour and then 
recording the absorbance at 530nm/590 nm with a micro plate reader. The absorbance values 
were normalized by the background readings. A standard curve of cell number that corresponds 
to MTS activity were constructed for the specific C2C12 used in the current study. 
4.2.6 Immunohistochemistry 
Myotube formation was evaluated on cells fixed after 11 days of differentiation. The C2C12 
cells cultured with differentiation media on pure  PCL matrices and electrically conductive PCL 
matrices were immunostained for sarcomeric-MHC and indicate myotube formation. The cells 
were washed with PBS and fixed with 4% paraformaldehyde (Sigma-Aldrich, St Louis, MO, 
USA) at room temperature for 15 min and then gently washed with PBS an additional two times. 
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Cell membranes were then permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, St Louis, 
MO, USA) in PBS for 5 min. After rinsing three times with PBS, nonspecific binding sites were 
blocked with 5% bovine serum albumin with protein blocker solution (Sigma-Aldrich, St Louis, 
MO, USA) for 30 min at room temperature. Following this, the samples were sequentially 
incubated with MF20 (1:200, Anti-MHC Alexa Fluor 488) over night at 4 °C. The stained 
samples were mounted with Vectashield containing 4', 6-diamidino-2-phenylindole (DAPI; 
Vector laboratories, Burlingame, CA) or Propidium Iodide (ThermoFisher Scientific)  and 
images were captured with confocal microscopy (Nikon A1 confocal). 
4.2.7 Quantitative RT-PCR  
The gene expression was evaluated via quantitative real-time polymerase chain reaction (qRT-
PCR) for the C2C12 cells cultured on different substrates after 6 days in differentiation medium, 
according to the following procedure. Total RNA was extracted from the C2C12s cultured on 
various substrates (n = 3) using the RNeasy Minikilt (Qiagen Sciences, Valencia, CA, USA). 
After RNA extraction, cDNA was prepared from 1µg RNA using reverse transcription reagents. 
Quantitative PCR was performed using Power SYBR Green PCR Master Mix. The expression 
levels of relative myogenic differentiation genes (MyoD, MyoG, Tnnt1) were measured by 
quantitative real time PCR (PCR system 7900HT). Quantification of target genes was performed 
relative to the reference glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene, using the 
following formula: relative expression = 2 [− (Ct sample – Ct GAPDH)] . The mean minimal 
cycle threshold values (Ct) were calculated from quadruplicate reactions. Then, the relative gene 
expression in each experimental group was normalized to the relative gene expression found in 
the reference sample.  
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4.2.8 ELISA analysis 
After 14 days of culture, the 10% PEDOT: PSS group, dopamine, and PCL group, initially 
seeded with C2C12 cells, were lysed using lysis buffer. The samples in lysing buffer were 
centrifuged and assayed using an ELISA kit (TNNI1 elisa kit: Mouse troponin I type 1 (skeletal, 
slow)) following the manufacturer instructions (myBiosource). The plates were read at 450 nm 
using 540 nm as the reference wavelength based on the manufacture’s instruction and analyzed 
using construction of a standard curve. The detection range of the kit is between 7.8 pg/ml-500 
pg/ml. Total protein of each matrix was determined using a commercially available BCA protein 
assay kit (Pierce, Rockford, IL, USA). The amount of TNNT1 on each matrix was also 
normalized to the total protein amount. 
4.2.9 Statistical Analysis 
All quantitative data were expressed as the mean ± standard deviation. Both one way and two-
way ANOVA tests were used.  The Tukey pairwise comparison test was performed on samples 
to determine significant differences. The assumptions for ANOVA were found to satisfy 
Levine’s test for homogeneity of variance and passed tests for normality. A value of p < 0.05 
was considered statistically significant. 
4.3 Results 
4.3.1 Cell morphology on matrices 
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Figure 22. SEM images of C2C12 cells on treatment groups after two hours of cell seeding. 
Based on this SEM image, no clear trend of cell attachment was found, indicating PEDOT 
coating did not affect short term cell attachment. (Here 100% means 100% PEDOT: PSS coated 
matrices dopamine polymerized PCL matrices, 33% means 33% PEDOT:PSS coated matrices 
dopamine polymerized PCL matrices, 10% means 10% PEDOT:PSS coated matrices dopamine 
polymerized PCL matrices,1% means 1% PEDOT:PSS coated matrices dopamine polymerized 
PCL matrices, DOPA means dopamine polymerized PCL matrices, PCL indicated PCL 
electrospun nanofiber matrices)  
PCL 
DOPA 
10% 
1% 
33% 
100% 
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Figure 23. C2C12 Attachment on PEDOT Coated PCL Nanofibers (2h) 
 Again, we can see that with two hours of cells seeding, around 20 to 30 k cells were attached on 
matrices. Although there is no significant difference between the groups, this could possibly due 
to high variance of each of the groups.  
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Figure 24.C2C12 Morphology on PEDOT Coated PCL Nanofibers-D3 
 70 
 
Figure 25. C2C12 Morphology on PEDOT Coated PCL Nanofibers-D7 
During sample processing, some of the samples were by day 7, under low magnification and 
high magnification, we can observe that cell patches were spread on electrospun nanofibers.  
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Figure 26. C2C12 Morphology on PEDOT Coated PCL Nanofibers-D14 
By day 14, all groups have shown to form patches of cell sheets here and there. The cells were 
well spread following nanofiber structure.  
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Figure 27.C2C12 Morphology on PEDOT Coated PCL Nanofibers-D21 
C2C12 morphology showed the cells were well spread on matrices. By 21 days it is very 
confluent. On all of the groups, cells were connected with each other and formed layers of 
sheets. By this time, nanofiber feature is hardly seen but it has provided excellent platform for 
cells to grow and proliferate. All in all, topographical cues may be provided for cells to grow and 
differentiate. 
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Figure 28. 100% PEDOT: PSS SEM morphology at D14 
Based on this figure, it suggested that even 100% PEDOT: PSS can have C2C12 cells proliferate 
on the matrices. Suggesting PEDOT: PSS is a biocompatible polymer.  
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4.3.2 Cell viability on Matrices 
 
 
 
 
 
 
 
 
 
 
Live dead staining showed that there are more dead cells on higher concentration of PEDOT: 
PSS but there is no obvious toxicity for all six groups. 
 
 
 
 
 
 
100%	 10%	33%	
1%	 DOPA	 PCL	
Figure 29. Cytotoxicity: Live dead staining 
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Figure 30. SEM image of C2C12 cells seeded on six matrices on day 3. 
 
SEM images suggested that C2C12 morphology showed the cells were well spread on all 
matrices. The conclusion is the matrices are biocompatible. We chose 10% PEDOT: PSS as 
optimized group as a balance between conductivity and biocompatibility for further study.  
4.3.3 Gene expression  
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Figure 31. Impact of PEDOT: PSS on myogenic differentiation (gene expression) 
To confirm the differentiation of cultured cells toward skeletal muscle, quantitative real-time 
polymerace chain reaction (qRT-PCR) analysis was performed on four genes recognized as 
important for skeletal muscle development (Figure 5). There was no significant difference in the 
expression level of the Myf5 gene among the groups. However, other genes such as MyoD, 
myogenic, troponin T, which are expressed at different stages of myogenic development, 
respectively, were over-expressed on the 10% PEDOT:PSS  substrate.Myf5 and MyoD 
expression is initiated upon cell activation, and MyoD expression is sustained in proliferating 
and differentiating progeny, while MyoG expression is associated specifically with late-stage 
myogenic differentiation. Tnnt1 is associated with muscle contraction.  There was a higher 
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expression of myogenic regulatory genes MyoD, and MyoG, Tnnt1 on the electrically 
conductive substrates compared to non- conductive substrates. The expression of almost all the 
tested genes for cells cultured on electrically conductive substrates was two to four times higher 
expression than cells from pure PCL substrates.  
4.3.4 MHC/Dapi  staining of matrices 
 
Figure 32. Impact of PEDOT: PSS on myotube formation. Representative images of 8 days 
MHC/dapi staining of C2C12 cells on (a) 10% PEDOT:PSS random electrospun nanofibers (b) 
Dopamine random electrospun nanofibers (c) Pure PCL random electrospun nanofibers  
We observed scattered formation of myotubes on the 10% PEDOT: PSS matrices and Dopamine 
matrices after 3 days in growth media and 5 days in the differentiation media with minimal 
myotube formation on the PCL only fibers (Fig. 9 a–c).  
4.3.5 Satellite cell sorting using flow cytometry 
The prospective isolation of purified stem cell populations has dramatically altered the field of 
stem cell biology, and it has been a major focus of research across tissues in different organisms. 
Muscle stem cells (MuSCs) are now among the most intensely studied stem cell populations in 
mammalian systems, and the prospective isolation of these cells has allowed cellular and 
molecular characterizations that were not dreamed of a decade ago[237].We followed a protocl 
a.10% D8  b.DOPA D8 c.PCL D8 
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that isolated MuSCs from limb muscles of adult mice by fluorescence-activated cell sorting 
(FACS). 
With this protocol, we isolate 250,000–350,000 quiescent MuSCs from hind limb muscles of a 
healthy, wild-type C57BL6 mouse aged 2 weeks. This is approximately twofold to fourfold 
greater than previously published protocols (ranging from 80,000 to 150,000 MuSCs per 
mouse)16,17,25. The yield of MuSCs that we obtain represents ~3–4% of the total population of 
mononucleated cells after antibody staining. The background signal in each channel when 
sorting for MuSCs from mice within this age range is low, thus allowing distinct separation of 
the VCAM1+Sca1−CD31−CD45− population (Fig.). When plated in culture conditions that 
promote differentiation, >99% of the sorted cells are myogenic, as determined by the presence of 
molecular markers, and >96% undergo terminal differentiation and fusion (Fig. ). 
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Figure 33. Satellite cell isolation by FACs 
We collaborated with Dr. Godhammer on isolating of mouse satellite cells. By FACs, we could 
observe that only 14% of the whole cell population ended up being satellite cells.  
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Figure 34.Phase micrographs depicting the morphology of mouse myogenic cultures seeded on 
Matrigel-coated dishes on (A). Day 3 (B). Day 7 
 
Cells were isolated by Pronase digestion and cultures were maintained in rich growth medium 
according to protocols detailed in this chapter. Panels A, B, show the cultures on days 3, 7 
respectively. Round cells observed during early culture days (A) are proliferating satellite cells. 
Multinucleated satellite myotubes can be observed on day 7 (B). 
 
4.3.6 Satellite cell immunochemistry(myotube formation after 7 days differentiation) 
 
A  B  
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Figure 35. Satellite cell immunochemistry (myotube formation after 7 days differentiation) 
The identity of satellite cells can be further confirmed by their characteristic protein expression 
using immunostaining with MF20/DAPI. A. Images were taken with a 20x 
objective(MHC/DAPI). B. Bright field of satellite cells 20x objective. C. Images were taken with 
a 10x objective (MHC/DAPI). D. Bright field of satellite cells 10x objective. It is observed that 
multinucleated myotubes on day 7.  
4.3.7 Cell proliferation on aligned electrospinning 
10 mL of the PCL solution was placed into the syringe in the electrospinner with a 2.5 mL/min 
flow rate, and 20KV at 15 cm distance at ambient temperature and humidity to obtain bead-free 
nanofibers. A rotator was used to produce sheets with aligned nanofibers. After optimization, 6 
V rotator voltage was chosen as optimum voltage for speed to produce consistent aligned 
A 
C 
B 
D 
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nanofibers. Fiber diameter ranges from 2um to 5um. It falls the same range as random nanofibers 
fabricated previously.  
 
 
Figure 36. 2-day proliferation study on both align and random electrospun nanofibers. 
The 2 Days C2C12 Cell proliferation study suggests that, generally, matrices that are fabricated 
with aligned nanofibers may have better proliferation activity than matrices made with 
randomly-oriented nanofibers. For instance, the aligned matrices treated coated with the 
conductive polymer (10% PEDOT: PSS) held an average of approximately 94K cells attached, 
whereas the randomly-oriented matrices with the same treatment only held on to an average of 
57K cells. 
The DOPA-PCL treatment groups followed the same pattern, with the aligned matrices housing 
an average of 79K cells and the randomly oriented held only 54K. 
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Figure 37. SEM images of aligned nanofibers(4000X). 
This figure showed a representative image of nanofibers. By tuning the optimum condition, we 
get nanofiber ranges from 2um to 5um, which is very consistent with what we got with random 
electrospinning matrices.  
4.3.8 factin/dapi staining of C2C12 cells on matrices 
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Figure 38. Representative images of 8 days factin/dapi staining of C2C12 cells 
 (a) 10% PEDOT: PSS align electrospun nanofibers (b) 10% PEDOT:PSS random electrospun 
nanofibers (c) Pure PCL align electrospun nanofibers (d) Pure PCL random electrospun 
nanofibers 
Factin and dapi staining showed that conducting polymer coated matrices supported cell 
proliferation, which is consistent with previous observation. Alignment of nanofibers may 
facilitate cell alignment than random nanofibers. The topographical cue combined with electrical 
cues may facilitate growth and fusion of myotubes along their longitudinal axis.  
4.3.8 Elisa expression 
  
 
a.10% PEDOT D8 Align  b.10% PEDOT D8 Random  
c. PCL D8 Align  d. PCL D8 Random  
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Figure 39. Protein expression Tnnt1 D14 (random and alignment) 
Since we know that conducting polymer promoted myoblast maturation, we further incorporated 
topographical cues to the matrix. Using electrospinning, we fabricated aligned matrices with 
fiber diameters in the same range as the random matrices.    
To quantitatively assess the level of protein expression on different matrices, Tnnt1 was 
measured at 14 days, after 11 days of post induction. In comparing all six groups, similar protein 
expression levels were observed between the aligned and random dopamine groups as well as 
aligned and random PCL groups, with the exception of aligned and random 10% PEDOT groups, 
where the protein expression were significantly higher than the rest four groups (p<0.001). 
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Aligned 10% PEDOT (A 10% PEDOT) showed slightly higher protein expression than randomly 
aligned 10% PEDOT (R 10% PEDOT) but no significant difference was detected. 
 
Figure 40. Normalized protein expression Tnnt1 D14 (random and alignment) 
Assessing the normalized data, similar conclusion can be determined from these graphs. Aligned 
10% PEDOT showed slightly higher normalized protein expression but no significant difference 
was detected. This suggested a mild synergistic effect of topographical and electrical cues on the 
differentiation of C2C12 myoblasts. Based on the study of a single factor (polymer conductivity) 
as well as dual factors (polymer conductivity and matrix alignment), the addition of a conducting 
polymer plays more important role in promoting myotube formation. 
4.3.9 MHC/dapi staining on align and random electro conductive matrices 
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Figure 41. Representative images of 14 days MHC/PI staining of C2C12 cells 
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on (a) 10% PEDOT: PSS align electrospun nanofibers (b) 10% PEDOT: PSS random 
electrospun nanofibers (c) Pure PCL align electrospun nanofibers (d) Pure PCL random 
electrospun nanofibers. 
It has been shown on Figure 9A that conducting polymer nanofibrous matrices (10%PEDOT 
align and 10% PEDOT random) promoted more myotube formation than  PCL nanofibers (A-
PCL and R- PCL). In addition, the incorporation of nanofiber alignment of 10% PEDOT aligned 
nanofibers induced muscle cell alignment and also further enhanced myoblast differentiation 
compared with the 10% PEDOT random nanofibers. 
4.3.10 Quantitative analysis 
 
 
Figure 42. Quantification of the myotube number, myotube length formed in (A) * p<0.05 
significantly different. 
By counting myotube numbers, aligned conducting polymer (A10% PEDOT) showed significant 
higher (p<0.05) number of myotube than random conducting polymer (R10% PEDOT). It 
showed more significant difference when compared with pure PCL nanofiber matrices (A-PCL 
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and R- PCL). When using imageJ to measure muscle length, we discovered a significant 
difference between A10% PEDOT to the rest of the three groups (p<0.005). A10% PEDOT 
showed an average of 153.21 ± 56.56 µm length, while R 10% PEDOT showed an average of 
95.97 ± 56.09 µm, A-PCL showed an average of 89.17± 56.09 µm, R-PCL showed an average of 
47.03 ± 20.86 µm.  
4.4 Discussion  
Previous studies have shown that electrically conductive substrate hold great potential in tissue 
engineering applications especially in neural tissue engineering[68][238][239][240][89]. Recent 
advancements have shown that tissue engineering matrices made of conducting polymers such as 
polyaniline[154][86], polypyrrole[104] or carbon nanotubes[241] can be used for localized 
electrical signals to seeded cells, thereby resulting in an organized community of differentiated 
muscle fibers[242]. Here the use of PEDOT: PSS further demonstrates that conducting polymer 
coated matrices could promote myoblast maturation see in Figure 1. PEDOT: PSS has its 
advantage due to its superior electrical, chemical and environmental stability as well as improved 
conductivity and thermal stability[243][175]. In our endeavor, PEDOT: PSS coating was applied 
on the modified PCL surface. It can be an alternative but straightforward approach to traditional 
electrochemical method, where conducting polymers are usually deposited on hard 
surfaces[244][245][246].It has been shown in our previous study this approach was stable and 
successful[243]. Here dopamine polymerization was used not only to change surface 
hydrophobicity but also to enhance myoblast adhesion to PCL. Since it is known that cell 
reorganization, motility, and adhesion are greatly affected by substrate surface wettability[163]. 
It was discovered based on Figure 2, dopamine polymerization and PEDOT: PSS coating did not 
affect nanofiber diameter. The concept is that the coating is stable and minimum coating of 
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PEDOT: PSS could provide efficient conductivity. By altering PEDOT:PSS solution 
concentration, it can be concluded that conductivity is directly correlated to PEDOT:PSS 
solution concentration. As anticipated, the conductivity of a substrate composed of PCL only 
was not in the detectable range, while matrices coated with PEDOT:PSS with the 100% group 
possessing average sheet resistance values of around 5× 104 Ω/☐ , 33% around 13× 105 Ω/☐, 
and 10%  around 17× 106 Ω/☐. 1% group did not show consistent conductivity as the surface 
coating concentraion might be too low. In this way, we may able to tailor the conductivity range 
muscle cell desires. The effects of electrical cues on cellular morphology, proliferation were 
studied using a cell viability assay, live/dead staining as well as SEM imaging. As shown in 
Figure 4(A), the coated PEDOT:PSS was non-cytotoxic to the myoblasts cultured on all six types 
of  matrices. With optimum concentraion, which is 1% and 10 %,  the conductive matrices 
promoted cell proliferation for up to 14 days of culture shown in 4(B). SEM images of all six 
groups showed that the cells were proliferting and spreading on the matrices in 4(C). This also 
suggested that dopamine polymerized matrix may not be a significant factor in promoting 
myotube formation although surface wettability has been changed. Furthermore, our results 
demonstrate that myotube formation, which requires the differentiation of myoblasts, was 
significantly influenced by the PEDOT: PSS coating at day 8 and day 14 in culture, as shown in 
Figure 5. More myotube formation was observed on 1% and 10% PEDOT: PSS. This indicated 
that under optimum concentration, Myoblasts expressed myosin heavy chain (MHC), a marker 
for more mature skeletal muscle[247]and fused into multinucleated myotubes on the electrically 
conductive substrates, with a greater number of multinucleated myotubes observed on the 
electrically conductive matrices as well. To further quantitatively confirm differentiation of 
cultured cells toward skeletal muscle, RT-PCR (Figure ) was conducted it was discovered that 
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troponin T, which is a muscle contraction marker, was over-expressed on the 10% PEDOT: PSS 
substrate. In addition, 10% PEDOT: PSS as well as dopamine group expressed significantly 
higher MyoD than pure PCL substrates. Based on all these findings, we chose 10% PEDOT: PSS 
for further study.  
The potential mechanism might be that the addition of conducting polymer promoted regulation 
of calcium levels within cultured myoblasts. Calcium is an intracellular messenger that plays 
important role in muscle cells for excitation–contraction coupling, as well as for modulating 
many aspects of cell physiology[248][163].  Yang et al. also discussed the fact greater 
proliferation as well as maturation of skeletal myoblasts to electrical stimulation by conducting 
polymer results may be regulated by L-type calcium channels present in the cell membrane. The 
mechanism might largely be to due increased intracellular calcium channels[163].   
Equally important, according to previous study, carefully designed nanotopography plays an 
important role in establishing the structural organization required for the generation of 
physiologically relevant and mature muscle tissues. Huang et al. indicated that myoblasts can 
sense the nanoscale and microscale topographic features in the extracellular space, which could 
facilitate cell orientation, interaction, organization as well as cell assembly[249].  
We further incorporated the feature of alignment into conductive matrices. Both random and 
aligned matrices were optimized at the same range of diameter (2 µm to 5 µm). When 
quantitatively assess the level of protein expression on different matrices, significantly higher 
Tnnt1 protein expression levels were observed on 10% PEDOT (both random and align). 
Aligned 10% PEDOT (A 10% PEDOT) showed slightly higher protein expression than randomly 
aligned 10% PEDOT (R 10% PEDOT) but no significant difference was detected.  
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This suggested synergistic effect electrical cues on the differentiation of C2C12 myoblasts. The 
alignment does not have a significant effect on the expression of myogenic proteins. However, 
we cannot confirm that the feature of alignment is negligible.  
Observation of the length and width of the myotubes is commonly used to detect myogenic 
differentiation[109].It is observed that more and longer striated myotube formation  on aligned 
10% PEDOT: PSS matrices (A10%)  In particular, the length of the myotubes formed on the 
fiber substrates was significantly increased on the A10% compared to the rest three groups 
(Figure 9A). The average length of the myotubes on the aligned nanofibrous A10% PEDOT was 
50% longer than the myotubes on random 10% PEDOT: PSS matrices (R10%). This showed that 
the conducting polymer may promote more myotube formation, but alignment helps form longer 
and more mature myotubes. This observation confirms with previous study in other labs. For 
example, Choi et al. reported that the length of myotubes derived from cultured human skeletal 
myoblasts for 7 days was time times longer on aligned-PCL/collagen fibers (approximately 1000 
mm) than on randomly oriented PCL/ collagen fibers (approximately 500 mm[152]. Huang et al. 
and Jun et al. also observed myotubes increased significantly when cells were seeded on aligned 
matrices[109][179]. Our observations suggest that fibers with electrically conductive properties 
together with alignment features are effective at enhancing myotube formation.  
4. 5 Conclusion 
We have successfully developed a novel method for the fabrication of electroconductive 
nanofiber matrices. The changes in myoblast maturation are here attributed to differences in 
conductivity and topographies, rather than surface wettability on the substrates. Dopamine 
polymerized PCL matrices may change surface wettablity but does not obviouly enhance 
myotube formation. More importantly, the PEDOT: PSS coating of low and medium 
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concentration (1% and 10%) were shown to induce increased expression of genes that play 
significant roles in myogenic differentiation, indicating that substrate conductivity could play an 
important role in engineering functional and biomimetic skeletal muscle tissues. 
Overall, we have demonstrated that electrically conductive materials, in combination with 
geometrically aligned electrospun nanofibers enhanced both myoblast differentiation and 
ultrastructural organization without the need for external electrical stimulation. This could be of 
great therapeutic benefit in clinical setting where severe muscle defect heavily affects volumetric 
muscle loss or muscle atrophy in rotator cuff injury.  
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CHAPTER 5. ROTATOR CUFF SURGERICAL MODELS  
5.1 Surgery Background 
Rotator cuff tears (RCTs) are the most common tendon injury seen in orthopedic patients. The 
challenge is that massive RCT does not heal spontaneously and results in poor clinical outcomes. 
Muscle atrophy and fatty infiltration in rotator cuff muscles are major complications of chronic 
massive RCT and are thought to be the key factors responsible for the failure of attempted 
massive RCT repair.  
However, the pathophysiology of rotator cuff muscle atrophy and fat infiltration remains largely 
unknown, and no small animal model has been shown to reproduce the histologic and molecular 
changes seen in massive RCT.  
Dr. Feeley’s group reported a novel rat massive RCT model, in which significant and consistent 
muscle atrophy and fat infiltration were observed in the rotator cuff muscles after rotator cuff 
tendon transection and denervation. Even after two weeks, the supraspinatus and infraspinatus 
muscle lost 25.4% and 28.9% of their wet weight after complete tendon transection, respectively. 
Six weeks after surgery, the average wet weight of supraspinatus and infraspinatus muscles 
decreased 13.2% and 28.3%, respectively. Significant fat infiltration was only observed in 
infraspinatus 6 weeks after tendon transection[211]. 
Dr Rubino’s group evaluated the changes in fatty infiltration of the rotator cuff after it is 
repaired. The supraspinatus muscle of 15 New Zealand white rabbits was unilaterally detached 
from the greater tuberosity. Six weeks after muscle detachment, 5 rabbits were killed to halt the 
process of fatty infiltration and 10 rabbits underwent primary repair of the rotator cuff. Six 
months after repair, the remaining 10 rabbits were killed, and the muscle specimens were 
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examined microscopically to evaluate the muscle with respect to fatty infiltration. What they 
found is that after repair of the rotator cuff, the process of fatty infiltration does not progress any 
further. The changes that take place in this rabbit model in the first 6 weeks after a rotator cuff 
tear appear to be irreversible even with successful rotator cuff repair. It has significant clinical 
relevance that the presence of fatty infiltration of a torn rotator cuff does not preclude a 
successful repair. The repair can prevent further progression and atrophy of the rotator cuff, but 
the changes that appear in the muscle as early as 6 weeks after a rotator cuff tear appear to be 
irreversible.  
In a large sheep model done by Dr. Feeley ’s group, twelve female adult sheep underwent an 
acute rotator cuff tear and immediate repair on the right shoulder. The left shoulder served as a 
control and did not undergo a tear or a repair. After six months, the repair group demonstrated an 
increase expression of muscle atrophy, fatty infiltration, fibrosis related genes. Significantly 
increased adipocytes, muscle fatty infiltration, and collagen deposition was observed in rotator 
cuff muscles in the tendon repair group compared to the control group. They found that rotator 
cuff muscle undergoes degradation changes including fatty infiltration and fibrosis even after the 
tendons are repair immediately after rupture[225]. Based on the literature of rat and rabbit model, 
6 weeks of unrepaired rotator cuff, even they are repaired, the fatty infiltration is irreversible. For 
sheep model, even acute repair of torn rotator cuff is done, the muscle atrophy is still occurring.  
Even after the surgery, the quality and functionality of the muscle is very important. Here we 
propose a biomaterial that can regenerate the muscle and prevent it from muscle atrophy.  
5.2 Surgical technique 
Two operations were performed on each animal: full-thickness supraspinatus tendon detachment 
and complete tendon reattachment. Anesthesia was induced and maintained using 2% to 5% 
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isoflurane mixed with pure oxygen through a facemask for both procedures. The left shoulder 
was operated on in all cases. A 1.5-cm skin incision was made directly over the anterolateral 
border of the acromion. The deltoid was detached from the acromion and split caudally for 0.5 
cm to identify the tendon of the supraspinatus. The supraspinatus tendon was completely 
detached from its bone insertion on the humeral head, marked with a 5-0 Prolene suture 
(Ethicon, Johnson & Johnson Medical Ltd., Berkshire, UK) at the musculotendinous junction, 
and allowed to retract medially. Deltoid muscle, superficial fascia, and skin were closed with 5-0 
Vicryl suture (Ethicon). Animals were allowed unrestricted cage activity and received analgesia 
(subcutaneous buprenorphine) every 12 hours for 3 days. The second operation to reattach the 
tendon was undertaken 3 weeks after the first procedure. Before the skin incision was made, the 
DBM or GraftJacket was rehydrated for 30 minutes in sterile normal saline at the operating table. 
A 2-cm skin incision was made in line with the supraspinatus muscle belly, ending anterior to the 
lateral end of the clavicle. This approach was perpendicular to the incision used for tendon 
detachment to make use of a virgin anatomic plane devoid of scar tissue. The muscle belly of the 
supraspinatus was identified and followed distally to reveal the tendon stump with the suture 
marker in the musculotendinous junction. Scar tissue between the tendon stump and its insertion 
was excised, and the tendon was grasped with a double-armed 5-0 prolene suture using a 
modified Mason-Allen technique.19 Despite traction on the tendon stump, it could not be 
directly brought back to the humeral head in any of the cases. The bare tendon-bone insertion 
footprint was decorticated with a No. 11 surgical blade until bleeding was seen. A custom-made 
dental drill was used to drill a 1-mm hole from the neck of the humerus to the bone insertion of 
the detached supraspinatus[218].  
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A layered wound closure was undertaken in a similar manner to the first operation, and the 
animals were permitted unrestricted cage activity. Postoperative analgesia (subcutaneous 
buprenorphine 0.6 mg) was given every 8-14 hours for 3 days.  
5.3 Results 
5.3.1 Demonstration of surgical repair process 
 
Figure 43.Exposure of Rotator cuff/Humeral head. 
Incision centered over the aromion in line with the humerus then curving posteriorly towards the 
spine of the scapula. Release Deltoid from acromion, undermine deltoid bluntly with tenotomy 
scissors to release it from humerus to increase its mobility. Depress humerus to access the 
subacromial space and expose RTC Tendons. 
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Figure 44. Exposure of Supraspinatus Muscle Belly and application of Matrix 
Palpate scapular spine, place belly of 15 blade scalpel against spine angled superiorly and release 
trapezius (but not supraspinatus). 
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Figure 45.Demonstration of continuity of supraspinatus muscle belly and tendon under the 
acromion 
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Figure 46.Mobility of the Humerus after releasing the Deltoid from the Acromion 
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Figure 47. Demonstration of Deltoid, Supraspinatus tendon, Infraspinatus tendon, Subscapularis 
tendon 
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Repair
 
Figure 48.Repair of Deltoid to AC Ligaments 
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Figure 49.Demonstration of tendon repair 
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Figure 50.Bone tunnel shown by needle 
5.3.2 Surgical complications 
In general, surgery that involves anesthesia, which includes rotator cuff surgery, poses 
complications listed as follows[250]: symptoms with light risk of stroke, heart attack, 
pneumonia, or blood clot, damages to adjacent nerves and blood vessels, infection in the 
shoulder. Besides, stiffness is common after rotator cuff surgery. 
Currently, there is little information available concerning the outcome of patients with infection 
after rotator cuff repair. Since we encountered surgical infections in our surgery process, we like 
to retrospectively review the incidence. There are clinical presentation, bacteriology, treatment, 
and outcomes of patients with rotator cuff repair complicated by deep infection.  
 105 
The diagnosis of deep shoulder infection was made at a mean of 49 days after the index surgery 
(range, 2-483 days); the median time to diagnosis was 30 days. Of 39 cases, 15 (38%) presented 
within 3 weeks, 14 (36%) presented at between 3 and 6 weeks, and 10 (26%) presented at more 
than 6 weeks, with 2 presenting at 12 and 16 months[251].  
The most common presenting symptoms included wound drainage in 28 shoulders, wound 
erythema in 25, increased pain in 18, and partial or complete wound dehiscence in 12.  
Seven patients presented with chronic mature sinus tracts with purulent drainage. Ten described 
constitutional symptoms such as fever or chills at presentation.  
Also, bacterial infection poses a threat to rotator cuff healing. According to the statistics, 
polymicrobial infection was present in 6 cases, with the remaining 33 being monobacterial 
[252][253].  
Surgical infection observation 
Surgery observation in chronic rotator cuff injury are written as follows: 
1. Externally the skin appears well healed. 
2. Upon incision, numerous fascicular connections are seen to connect the skin to 
underlying musculature. 
3. The suture-repair of the deltoid and trapezius at the acromion appear to be not completely 
healed. 
4. Inflammation and redness is observed around the acromion. 
5. Likewise, major swelling is seen, making the area posterior to the acromion located 
above and posterior to the humeral head bulged. 
6. The surface of this bulge appears to have a combination of darkened read, greenish, and 
yellowish coloration. 
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7. Upon puncture of this bulged area, plain viscous liquid, or greening puree oozes (sepsis) 
8. The bulge appears to be composed of scar tissue, careful removal of which reveals the 
underlying bone, and tendon to bone repair. 
9. In some samples, the suture through the bone tunnel has ripped out of the bone tunnel; 
likewise, there is often a gap between the tendon foot and the bone to which it is attached 
via suture. This gap is sometimes seen filled by scar tissue. 
During our first surgery, there are two complications that are occurring infection rate and suture 
coming out.  
 
Figure 51.images of surgical infections with puss 
The complication rate is listed as follows:  
Group 1: (control 1) (0 out of 6) Sham surgery: 0% 
Group 2:  Acute repair (0 out of 8): 0%  
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Group 3: tendon tear: (0 out of 8) 0%  
Group 4: Rotator cuff acutely injured, 2 wks. later repaired with suture sacrificed at 2 wks. (2 out 
of 4) 50%, at 6 wks. (2 out of 4) 50%  
Group 5: Rotator cuff acutely injured, 2 weeks later repaired with suture and place 10% PEDOT: 
PSS nanofiber matrices on supraspinatus muscle, sacrificed at week 2(2 out of 4) 50% , week 6 
( 3 out of 4) 75%  
Group 6: Rotator cuff acutely injured, 6 wks. later repaired with suture sacrificed at 6 wks.(0) 90 
out of 4)  0% 
Group 7: Rotator cuff acutely injured,6 weeks later repaired with suture and place 10% PEDOT: 
PSS nanofiber matrices on supraspinatus muscle, sacrificed at week 2 (2 out of 4) (50%) 
 
Figure 52.Infection rate of 2 weeks tendon tear and 6 weeks tendon tear only 
According to the analysis, 2 weeks tendon tear and coming back to repair seems to cause more 
infection. It makes perfect sense as we surgically tear the tendon and waited only two weeks to 
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fix the rotator cuff. It has caused more trauma than doing good. That was the reason we later 
decided to drop this surgery group. 
Suture breaking out of the bone tunnel 
During surgery process, we found several incidences that suture breaks out of the bone tunnel. 
The number is listed as follows:  
Acute repair: 1 out of 8   
Sub-acute repair: 1 out of 24 (no infection)  
                                11 out of 24(infection) 
 
 
Figure 53. Incidence rate of suture breaking out of bone tunnel 
 
The reason why suture is breaking out of the bone tunnel might be mostly due to bacterial 
infection. 
Microbial infection usually caused by bone osteolysis (suture breaks out of the bone tunnel) 
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Figure 54.X ray images of bone dissolving in one of the infected rotator cuff case 
 
The X ray suggested that the part of the bone is gone potentially due to aseptic necrosis of the 
humeral head. It occurs when part of the bone does not get sufficient blood and then dies. The 
bone will further break out if the condition is not treated and will lead to potential collapse.   
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After a while part of the bone breaks off. If this condition is not treated, bone damage gets worse. 
Eventually, the healthy part of the bone may collapse. In our case, Aseptic necrosis can be 
mainly caused by severe trauma as we have done intensive surgery procedures to a single rat 
within short period of time.  
Aseptic necrosis can be caused by many reasons such as disease, or a severe trauma, or even 
break or dislocation, that affects the blood supply to the bone. Many times, no trauma or disease 
is present. This is called “idiopathic aseptic necrosis” — aseptic necrosis without any known 
cause[254]. 
5.4 Conclusions 
In general, better precautions should be taken in order to prevent surgical infection. Here are 
some measures we took during our follow up surgeries. It turned out to be successful: First of all, 
we used antibiotics two days prior the surgery. We used one packet of equipment for each 
surgery. Surgical gowns were changed every three cases. There was no touching other non-
sterile equipment during surgery. Further, we exposed only shoulder side during surgery proper 
cutting on the drape and performed less surgeries per day. We also tried to maintain the integrity 
of blood vessels[251]. As discussed before, we decided to drop the two weeks tendon tear group 
and then come back to repair as it doesn’t have too much clinical relevance.   
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CHAPTER 6. EVALUATION OF BIOLOGICAL 
PERFORMANCE of THE OPTIMIZED NOVEL 
ELECTROCONDUCTIVE MATRICES IN RAT ROTATOR 
CUFF MUSCLE ATROPHY MODEL 
6.1 Introduction  
Rotator cuff injury remains to be one of the most challenging orthopedic conditions that affect 
more than 40% of elderly over 60 in the US [209,210]. Rotator cuff tears especially chronic 
rotator cuff tears are hard to treat because of the injury time [210,255].  They are often associated 
with a set of pathologic changes occurring in torn rotator cuff muscles, including muscle atrophy, 
smaller muscle cross-section area, lipid accumulation in and around muscle fibers, larger 
intramuscular spaces, and fibrosis [256,257]. These changes are referred to as ‘‘fatty 
degeneration ” [223]. Despite successful repair of the tendon to the bone insertion site, the 
clinical outcome is compromised by factors listed above [258]. For example, Goutallier et al. 
demonstrated the high correlation of recurrent tear with advanced degrees of fatty atrophy among 
220 patients [258]. A cohort study on rotator cuff retears rate after repair surgery is 7.22% and 
fatty infiltration one of the primary reasons [255].  
Therefore, preventing the adjacent muscle degeneration is critical to achieving favorable clinical 
outcome after tendon repair. So far, multiple studies have been focusing on applying repair 
techniques [215], using biologic factors [216] or biomaterials [217,218] to improve tendon to 
bone healing. 
At the same time, animal models are useful tools to study the molecular mechanisms of muscle 
atrophy, fatty infiltration, and fibrosis that are observed in the setting of rotator cuff tears in 
patients [225]. Much research has been done to study the progression of muscle atrophy 
[213,225,258].  Various animal atrophy models such as rats [222], rabbits [259] or sheep [225] 
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have been utilized to determine the timely changes that take place in the region of supraspinatus 
muscle after tendon detachment [220,221]. It was hypothesized that tendon detachment would 
lead to lack of load thus would cause significant muscle weight loss as well as a conversion of 
the muscle types [222]. 
In summary, there is a need, and a gap for emerging strategies not only to provide effective 
reinforcement of rotator cuff repair but provide novel treatment methods to enhance the patient’s 
intrinsic healing potential[260]. 
It is the study interest that biomaterial strategies can potentially address muscle atrophy issue in 
rotator cuff injury, which has not been well studied before. Biomaterials that containing 
electrical cues is one of the new ways to change surface functionality as it can stimulate tissue 
repair and regeneration [86]. Various studies showed a positive effect of conducting polymer 
such as polypyrrole (PPy) [104], polyaniline (PANI) [261] in promoting myoblast 
adhesion/proliferation [104]as well as maturation.  
This could be revolutionary on how rotator cuff repair is being treated. In our study, the potential 
effects of electrospun nanofibers containing conducting polymer PEDOT: PSS have been 
previously explored in vitro and showed positive results [262].  Thus, the purpose of this study 
was to evaluate how intrinsically conductive matrices stimulate muscle regeneration, thereby 
suppressing fatty expansion.  
6.2 Material and Methods 
6.2.1 Study Design 
In this study, we have developed a chronic rotator cuff repair model utilizing adult male Sprague 
Dawley rats weighing between 400 grams to 450 grams. We first used an open surgical approach 
to create a full-thickness rotator cuff tear of the supraspinatus tendon. After chronic (42 days) 
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tear, we went back and performed surgical repair of supraspinatus tendon to 20 animals with or 
without the insertion of PEDOT: PSS matrices at the same time. Briefly, during tendon repair, a 
small incision is made through the trapezius muscle at the scapular spine, exposing the mid-belly 
of the supraspinatus (SS) muscle. Then, a 0.6cm(length)*3 cm (width) PEDOT: PSS matrix was 
sutured into the belly of the SS to induce a cycle of regeneration. Supraspinatus, infraspinatus, 
and control supraspinatus tendon and muscle were exposed and removed for histological analysis 
at specific time points after the procedure. We also performed an immediate repair to those acute 
groups, that is we tear the tendon and then we immediately repair the injury.  We then measured 
changes in muscle mass, tendon length, and the number of fibers of fast type muscle and slow 
type muscle. Differences between groups were tested using a one-way ANOVA followed by 
Tukey's post hoc sorting. The surgical groups are listed as follows: Group 1: (control 1) Sham 
surgery, sacrificed at two weeks(n=3) and six weeks(n=3). Group 2: (control 2): Rotator cuff 
acutely injured without repair, sacrificed at week 2(n=4), week 6(n=4). Group 3: Rotator cuff 
acutely injured, six weeks later repaired with suture, sacrificed at week 2(n=4), week 6(n=6). 
Group 4: Rotator cuff acutely injured, six weeks later repaired with suture and place 10% 
PEDOT: PSS nanofiber matrices on supraspinatus muscle, sacrificed at week 2(n=4), week 
6(n=6). Group 5: Rotator cuff acutely injured, immediately repaired with suture and place 10% 
PEDOT: PSS nanofiber matrices on supraspinatus muscle, sacrificed at week 6(n=6). Group 6: 
Rotator cuff acutely injured, immediately repaired with suture, sacrificed at week 6(n=6)  
6.2.2 Preparation 
As previously described, Briefly, substrate material was electrospun using an optimized aligned 
setup with electrospinning parameters of 15 % (w/v) PCL solution in ethanol and methylene 
chloride (15:85 ratio). Dopamine (2mg/ml) was applied to the surface for 24 hours at pH 8.5 to 
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polymerize onto the surface of the PCL fiber mats and form a polydopamine coating[115]. The 
modified DOPA-PCL surfaces were washed, dried, and subsequently coated with 30 µl of 10% 
PEDOT: PSS solution, where the 10% solution indicates a PEDOT: PSS 1.3wt% dispersion in 
H2O and are further diluted ten times with PBS.  The dried matrices were treated with mild 
13.3% acetic acid, which is pH 2 to enhance its conductivity.  
6.2.3 Tissue Harvest 
Rats were sacrificed at 2 and six weeks after surgery. Both supraspinatus and infraspinatus of 
surgical side and supraspinatus of control side were harvested, and the remaining tendon and scar 
tissue were removed at the muscle/ tendon junction. The wet weight of muscle was weighed 
immediately. The length of supraspinatus and infraspinatus were also measured at the time of 
harvest. After the measurement was done, the harvested muscle was divided sharply into the 
half. One was used for paraffin embedding, and the other half was used for frozen section. 
6.2.4 Wet Weight measurement  
The supraspinatus and control supraspinatus muscle were dissected origin along the 
supraspinatus fossa of the scapula and the distal tendinous attachment. The wet mass of the 
supraspinatus muscle was measured with use of a digital scale immediately after dissection 
(Ohaus® Voyager Pro balance). Since sham group and tendon tear group are harvested at six 
weeks post-surgery and two sub-acute repair groups are harvest 12 weeks post their first surgery. 
We decided to use relative percentage weight change to measure the weight difference between 
the different groups. The weight change percentage was calculated as   Relative	𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒	𝑤𝑒𝑖𝑔ℎ𝑡	𝑙𝑜𝑠𝑠
= ;control	supraspinatus	weight	 − supraspinatus	weightsupraspinatus	weigh G × 100% 
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6.2.5 Immunochemistry Analysis  
Following existing protocol, between two and four cry sections (10 um-thick) cut from the mid 
muscle belly will be rehydrated in phosphate-buffered saline (PBS), fixed in 4% 
paraformaldehyde, washed in PBS, and immersed in 5% normal donkey serum for 15 min [233].  
Above tissue sections will be imaged and quantified using immunohistochemistry for fast type II 
myosin heavy chain (MHC) isoform, slow type I MHC isoform, and C/EBPa using fluorescence 
labeling methods[233]. 
6.2.6 Histological Analysis 
Muscle samples from all experimental groups were cut in half as previously described. The 
entire half was fixed in 10% neutral buffered formalin and stored in 60% ethanol. All samples 
were processed (ASP300S; Leica Microsystems, Bannockburn, IL) and then embedded in 
paraffin (EG1160; Leica Microsystems). Eight to ten-mm-thick serial sections were cut from the 
paraffin-embedded blocks and Masson's Trichrome staining, and Hematoxylin & Eosin staining 
were performed to identify fibrotic tissue and muscle fiber outlines[232][233]. 
Immunohistochemical staining was performed using antibodies to detect fast myosin 
(NovocastraTM Lyophilized Mouse Monoclonal Antibody Myosin Heavy Chain (fast), 1:10; 
Leica Biosystems) and Vascular ECs were identified by immunohistochemical for Mouse 
monoclonal [P2B1] to CD31(Abcam, Cambridge, MA, USA), regenerating muscle cells were 
identified by Anti-NCAM antibody [RNL-1] (Abcam, Cambridge, MA, USA). Images were 
captured and digitized (DM4000B Leica Upright Microscope; Leica Microsystems) at varying 
magnifications. 
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6.2.7 Muscle Cross Section Area quantification  
To determine the muscle-fiber cross-sectional area, a transverse section of the supraspinatus 
muscle was harvested from the different surgical group. Sections were embedded in paraffin as 
previously described. Sections were visualized at X10 magnification (Leica Microsystems, 
Wetzlar, Germany) and images were recorded with use of a digital camera. For Masson's 
trichrome staining, all complete fiber structure were counted and measured.  For fast muscle 
staining, the cross-sectional areas of fifty random muscle fibers per muscle were selected. In both 
ways, the selected muscle fibers were subsequently measured with use of ImageJ v1.32 image- 
analysis software (National Institutes of Health, Bethesda, Maryland). Muscle samples were 
analyzed in a random order, random selection and the investigator was blinded as to which 
muscle was being analyzed as only particular serial numbers were given. All the selection with 
their location information is stored in ROI manage in the form of Zip file for publication 
purpose. 
6.2.8 Muscle Gap quantification 
After the tendon is torn in rotator cuff injury, there will be a massive gap between the tendon and 
the bones, keeping the shoulder muscle from performing its usual actions of shortening and 
lengthening. At the same time, the human body tends to fill the gap with fat instead of muscle 
and this process is not reversible. However, the resultant outcome will be weak muscle with 
reduced functionality. Clinically it cannot be fixed, but repair surgery can prevent fatty 
infiltration from progressing further. Various studies have demonstrated that more fat will lead to 
a higher the risk of suboptimal healing after rotator cuff surgery[263]. It is therefore essential to 
quantify gap areas between muscle fascicles. 
Fuji image j analysis is used in muscle gap quantification. We evaluated the effect of surgery by 
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quantifying gap areas. Nine representative images with 350 µm *  350 µm dimensions were 
selected from each group with their specific location labeled in ROI manager. The detailed steps: 
1. Open Fuji imageJ 
2. Go to Analyze – Set Scale 
3. Distance in pixels: 220 known distance 100 unit length um.  
4. Go to Edit- Selection – Specify 
5. Randomly crop 350 µm *  350 µm area and duplicate and save 
6. Go to Image – Split channels-Select only green channel 
7. Go to Image –Adjust –Threshold(85 to 255) 
8. Go to Analyze- Set Measurements-(select area, area fraction, mean gray value, limit to the threshold, 
display label, add to overlay) 
9. Save the location of selection in ROI manager. 
10. Go to Analyze and then click Measure 
11. Save the area value and area percentage in excel file 
12. Use prism for quantitative analysis 
6.2.9 Statistical Analysis 
6.2.9.1 Power Analysis 
Power analysis was used to determine effective animal size in this study. It is the first time we 
study muscle atrophy in rotator cuff model with matrices implantation. Preliminary data to see 
the statistical difference was based on volumetric muscle loss(VML) with matrix 
implantation[174]. In the calculation, treatment group percentage change was normalized with 
control groups. Mean, and the standard deviation was then calculated. Power analysis was based 
on 𝛼=0.05 and 𝛽=0.80. Then, a literature review was done to calculate effective animal size 
under each index. 
Muscle volume index 
Page, R L et al. did an estimation of the regenerated tissue volume. They found 35% more mean 
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total muscle area compared to untreated group by 30 days, 53.8% more mean total muscle area 
compared to untreated group by 120 days.[264] 
In another study done by Ward et al., they found that fifty percent graft repair significantly 
increased fiber number by 20% compared with no repair. One hundred percent graft volume 
repair resulted in a significant increase in fiber number compared with all other VML injured 
muscles (e.g., *41% > nonrepaired), but did not achieve full fiber restoration (i.e., *14% < 
contralateral uninjured muscle)[171]. 
In the study done by Y. Ju et al., they found that the number of regenerated muscle fiber 
increased by 100% between matrices loaded with IGF-1 and control groups. [265] 
Table 1. Muscle volume calculation based on literature review 
 muscle volume calculation 
 1.35 
 1.41 
 2 
sd 0.359212101 
average 1.586666667 
 
 
Figure 55.Power analysis based on muscle volume index 
Based on power analysis, n=4 is required if we do use this metric in our study. 
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Pax7: 
In the study done by Y. Ju et al., to identify the infiltrating cells, the retrieved matrices were 
examined by immunohistochemistry for muscle progenitor cell marker, Pax7. Around 133% 
increase between IGF-1 and control after two weeks.[265] 
Another study was done by page et al., the treated implants for VML showed 100% more Pax 7 
than untreated ones .[264] 
In the study done by B.Corona,  Pax7 was 13.3% higher from 1SPD to 1SP(media 
condition)[206] 
Table 2.Pax 7 indexes based on literature review 
 pax 7 
 2.33 
 2 
 1.33 
average:  1.886666667 
sd 0.509542278 
 
 
Figure 56. Power analysis based on pax seven index  
Based on power analysis, n=3 is required if we do use this metric in our study. 
MHC  
Immunohistochemical staining for MHC demonstrated newly formed muscle fibers, as 
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evidenced by centrally located nuclei, in the defect site. Around 200% percent increase between 
IGF4 and control group.[265] 
Muscle weight index:  
In the study done by Aurora, Amit et al. compared rat exercised and sedant after VML surgery: 
The primary findings of the study are that physical rehabilitation in the form of voluntary wheel 
running promoted around 13% increase in weight of the injured muscle. [266] 
In the current standard VML model by Wu, resulting in significant compensatory hypertrophy of 
the EDL. That is, the initial loss of approximately 20% of TA muscle mass was associated with 
an approximate 15% and 17%increase in EDL muscle wet weight 2 and four months postinjury, 
respectively. [204] 
In the development of tissue-engineered muscle repair (TEMR) constructs (i.e., muscle-derived 
cells [MDCs] seeded on an acellular bladder matrix (BAM) preconditioned with uniaxial 
mechanical strain) for the treatment of VML. TEMR constructs were implanted into a VML 
defect in a tibialis anterior (TA) muscle of Lewis rats and observed up to 12 weeks postinjury. 
The BAM group showed a 12.8% increase in TA muscle weight compared to unrepaired 
samples. [174] 
Table 3.Muscle weight index based on literature review 
 muscle weight  
 1.13 
 1.15 
 1.18 
average 1.153333333 
sd 0.025166115 
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Figure 57.Power analysis based on muscle weight index 
Based on power analysis, n=1 is required if we do use this metric in our study. 
As we can divide muscle into half for characterization, useful size n=4 is enough for each group. 
6.2.9.2 Tukey pairwise comparison test 
To quantitatively determine if there is a difference between the sham group, tendon tear group,  
surgery repair groups with or without matrices, multiple images(6 to 9 images per group) are 
pulled from representative images. Muscle cross-section areas are labeled as the mean and the 
standard error of the mean. A p value of <0.05 was considered significant. Differences between 
groups were determined using one-way ANOVA with Tukey's post test, or, where appropriate, 
Student's t-test. 
6.3 Results and Discussion 
6.3.1 Tendon contraction  
Table 4.Two weeks and six weeks tendon retraction 
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Tendon contraction was measured. It was listed as below:  
 
Figure 58. Two weeks and six weeks tendon retraction 
As the mean retraction for two weeks is around 6.5mm while meaning retraction for six weeks is 
around 6.733 mm. Although six weeks the tendon retraction is slightly higher than two weeks, 
there is no significant difference regarding tendon retraction between 2 weeks and six weeks. It 
2 weeks tendon retraction 6 weeks tendon retraction
Number of values 10 15
Minimum 5 5
25% Percentile 6 6
Median 6 7
75% Percentile 7.25 7
Maximum 8 10
Mean 6.5 6.733
Std. Deviation 0.9718 1.163
Std. Error of Mean 0.3073 0.3003
Lower 95% CI 5.805 6.089
Upper 95% CI 7.195 7.377
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is reasonable as once the tendon is retracted to some extent, it will not progressively retract 
tremendously. However, the standard deviation of six weeks' retraction is higher than two weeks' 
retraction. 
We used reduced supraspinatus percentage to measure supraspinatus weight loss on the surgical 
side compared to the nonsurgical side (Fig.58). The equations listed as follows: Reduced 
supraspinatus percentage= (Control supraspinatus weight- surgical supraspinatus weight)/Control 
supraspinatus weight. 
6.3.2 Sub-acute rotator cuff repair  
6.3.2.1 Wet supraspinatus weight measurement 
 
Figure 59.Reduced supraspinatus percentage with Sub-acute repair six weeks 
There were apparent gross morphometric changes in the muscle at 2 and six weeks following 
surgery. 
The supraspinatus muscles appeared noticeably smaller than the control muscle on the 
contralateral side in the tendon tear only groups. Quantitatively, the reduced supraspinatus 
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percentage of this tendon tear only group was statistically significant than other groups (at least 
p<0.05) at two weeks as well as six weeks. For sham groups, they went through minimal 
supraspinatus weight loss at two weeks compared to other groups. At six weeks, the wet weight 
of surgical supraspinatus was higher than control supraspinatus, indicating possible complete 
healing of muscle. It was noticeable that after rotator tendon being repaired, the difference of 
weight loss between the surgical side and control side was much smaller than tendon tear groups 
from two weeks to six weeks. 
However, no significant difference was observed between sub-acute repair and sub-acute repair 
with matrix groups in the reduced supraspinatus percentage regarding with the wet weight.  
 
6.3.2.2 Histology Analysis 
Fat cells were only observed in tendon tear groups. Indicating the successful repair can prevent 
fat cells from proliferating. 
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Figure 60. Fat cells proliferation of tendon tear group 6 weeks 
For the tendon tear only group, more gaps were observed between muscle fascicles. Fat cells 
start to  
infiltrate and proliferate between these muscle gaps.  
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Figure 61. Significant Fibrosis on six weeks tendon tear group 
Based on the Figure, more fibrosis was observed on tendon tear the only group both in H&E 
staining and Masson's Trichrome staining. 
 
 
H&E staining Masson’s trichrome  
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Figure 62. MyHC II fibers (fast muscle type) staining on tendon tear the only group  
Consistent with the result in H&E staining and Masson’s staining, more fibrosis were observed 
on tendon tear groups six weeks post-surgery.   
 
 
 
Figure 63 H&E staining Sub-acute repair 2wks 
 
Hematoxylin and eosin staining of the rat supraspinatus muscle (Fig 63. Demonstrated 
morphologic changes in the transected rotator cuff muscle compared to control sham groups. The 
muscle cross sections were smaller after six weeks tendon tear compared to the sham group, with 
increased fibrosis of and irregular muscle structure. There is fibrosis present in both sub-acute 
A. Sham group B. Tendon tear only 
C. Sub-acute repair with  
suture 
D. Sub-acute repair with  
matrix 
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repair groups but not as significant compared with tendon tear only group. The muscle fiber 
looked organized and short 6 weeks after successful surgical repair. (Figure below) demonstrates 
fast muscle growth on a matrix, indicating potential muscle regeneration on electrically 
conductive matrices. 
 
Figure 64. H&E staining Sub-acute repair 6wks 
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Figure 65.Masson Trichrome staining of different groups at 2wks 
Mason Trichrome staining showed similar study result that tendon tear groups had wider gaps in 
between and had more fibrosis. The packing and orientation of muscle fibers are more regular in 
Sub-acute repair with matrix group then suture group alone. 
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Figure 66.Masson Trichrome staining of different groups at six weeks post-surgery 
Six weeks Masson Trichrome staining further confirmed by showing dense packing of muscle 
fibers in groups which were repaired with matrices 
Muscle gap area quantification 
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As previously described, we used ImageJ to convert Mason image to a binary scale, in this way 
we can quantify the percentage of the gaps. 
 
 
Figure 68.Gap Area between Muscle Fascicles 6 weeks sub-acute repair 
After the tendon is torn in rotator cuff injury, there will be a considerable gap between the tendon 
and the bones, keeping the shoulder muscle from performing its usual actions of shortening and 
lengthening. 
Figure 67.Masson Trichrome staining of different groups at six weeks post-surgery 
 132 
Various studies have demonstrated that more fat will lead to a higher the risk of suboptimal healing 
after rotator cuff surgery [263]. The quantification of these intrafibrillar spaces also termed as gap 
area here is, therefore, an essential indication of muscle atrophy. 
Tendon tear only group had more gap between muscle fascicles with mean gap percentage around 
20.34%, which was statistically higher than the rest of the groups. Sham group had smallest gap 
area with low 5.367%. It also showed a statistical difference compared with the rest three groups. 
Sub-Acute repair with matrix had less gap percentage (9.823%) than Sub-Acute repaired with 
suture repair only (15.14%) (p<0.01). The potential mechanism was that with the aid of matrices, 
the stimulus effect prevented muscle gap from forming so that the average muscle area was more 
significant compared with suture only group. 
Below is the result of a Tukey test of pairwise comparison and degree of significance 
Table 5.Tukey test of pairwise comparison on Gap Area between Muscle Fascicles 6 weeks  
sub-acute repair groups 
 
Tukey's multiple 
comparisons tests 
Mean Diff. 95.00% 
CI of 
diff. 
Significant? Summary Adjusted P 
Value 
Sham group vs. Tendon 
Tear 
-14.97 -19.11 to 
-10.84 
Yes **** <0.0001 A-
B 
Sham group vs. Sub-
acute repair with suture 
-9.777 -13.98 to 
-5.571 
Yes **** <0.0001 A-
C 
Sham group vs. Sub-
acute repair(matrix) 
-4.457 -8.662 to 
-0.2507 
Yes * 0.0341 A-
D 
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Tendon tear only vs. 
Sub-acute repair with 
suture 
5.196 1.264 to 
9.129 
Yes ** 0.0053 B-
C 
Tendon tear only vs. 
Sub-acute repair(matrix) 
10.52 6.585 to 
14.45 
Yes **** <0.0001 B-
D 
Sub-acute repair with 
suture vs. Sub-acute 
repair(matrix) 
5.321 1.311 to 
9.331 
Yes ** 0.0051 C-
D 
Muscle cross-section area using Mason's Trichrome staining 
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Figure 69.Muscle cross-section area using Mason's Trichrome staining 
The muscle-fiber cross-sectional area decreased at six weeks from 2905 ± 134.3 um2 in sham 
group to 1421± 100.9 um2 (p<0.0001) in tendon tear only group, from 2905 ± 134.3 um2 in sham 
group to 1629± 94.81 um2 (p<0.0001) in sub-acute repair with suture group and 2905 ± 134.3 
um2 in sham group to 1983± 88.06 um2 (p<0.0001) in sub-acute repair with suture. Sub-acute 
repair with matrix (1983± 88.06 um2) has higher muscle cross-section area compared with sub-
acute repair with suture only (1629± 94.81 um2, p<0.001). The degree of cross-sectional area 
reduction was dramatic in tendon tear the only group.  
Based on the result, it is discovered that the sham group has the highest average muscle cross-
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section area compared with rest of the three groups(p<0.0001). Tendon group has the smallest 
muscle area compared with sub-acute repair with suture or Sub-acute repair with 
matrix(p<0.001). Sub-acute repair with matrix has a higher muscle cross-section area compared 
with sub-acute repair with suture only. This suggested that prevention of muscle from shrinking 
is achieved with the aid of matrix. It is also consistent with muscle gap quantification.  
Fast muscle staining 
 
Figure 70.Fast muscle staining sub-acute repair at two weeks’ time point 
At two weeks, in the thick tissue layer, all groups have both fast muscle and slow muscle. 
However, fast muscle has a dominant percentage (stained brown compared to those unstained). 
A. Sham group 
C. Sub-acute repair with 
suture 
D. Sub-acute repair with  
matrix 
B. Tendon tear only  
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Figure 71.Fast muscle staining sub-acute repair at six weeks’ time point 
 
Until six weeks, the slow muscle has almost disappeared in the tendon tear group. It is consistent 
with previous literature that MyHC I fibers (slow muscle type) are more are more vulnerable to 
atrophy induced by external forces such as denervation as well as immobility because they have 
a higher protein metabolic rate.  MyHC II fibers (fast muscle type) are more sensitive to 
cachexia, chronic heart failure, chronic obstructive pulmonary disease as well as aging[267]. 
 
 
A. Sham group B. Tendon tear only  
C. Sub-acute repair with 
suture 
D. Sub-acute repair with 
 matrix 
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Figure 72. Type I muscle composition change from 2 weeks to 6 weeks 
According to MyHC classification of muscle fibers, MyHC I, MyHC II correspond to muscle 
fiber Types I, II [267]. It was observed that the majority of the rotator cuff muscle fibers in the 
rats were made up of Type II (fast). MyHC II staining which was shown in brown while MyHC I 
fibers was left unstained and showed white. Until six weeks, the slow muscle had almost 
disappeared in the tendon tear the only group. It was consistent with previous literature findings 
that MyHC I fibers (slow muscle type) are more vulnerable to atrophy induced by external forces 
such as denervation as well as immobility because they have a higher protein metabolic rate. 
MyHC II fibers (fast muscle type) are more sensitive to cachexia, chronic heart failure, chronic 
obstructive pulmonary disease as well as aging [267]. At two weeks, in the thick tissue layer, all 
groups had both fast muscle and slow muscle. However, fast muscle had a dominant percentage 
(stained brown compared to those unstained). 
 
Consistent with what we saw in the images in Figure 6A, there was less type I muscle in all the 
groups as they are susceptible to injury Figure 6B. Tendon tear the only group had the smallest 
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type I muscle percentage. Unstill six weeks, Tendon tear only group still had the lowest type I 
percentage while sham group and Sub-Acute repair with suture with or without matrices showed 
an increase in type I muscle. Sub-Acute repair with matrices showed a statistical difference 
compared with the tendon tear only group. 
 
 Muscle cross-section area using fast muscle staining 
A. 
 
B. 
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Figure 73. A.  Muscle cross-section area statistical measurement between different groups at six 
weeks' time point. B. Random selection of 50 muscle fibers with three replicates in each group. 
For each group, 3 to 4 representative images were selected, and we randomly selected fast 
muscle fiber cross section area for measurement. We can find that sham group (3548± 92.06 
um2) showed statistically higher fast muscle fiber area than the rest three groups. Tendon tear 
group (1836± 92.06 um2 ) has the smallest average fast muscle cross-section area compared with 
two sub-acute repair group(p<0.001). Sub-acute repair group with suture (2618 ± 92.22 um2) has 
no significant difference compared with Sub-acute repair with matrix (2724 ± 92.37 um2), but it 
showed a slightly higher fast muscle cross-section area. The reason for fast muscle area higher 
than Masson's staining measurement is that Masson's staining accounts for both types of muscle 
fibers. Also, the quantification method can be further improved. 
The progress of muscle cell infiltration 
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Figure 74.Fast muscle cells infiltration on electroconductive matrix from two weeks to six 
weeks. 
The host response to muscle atrophy treated with conductive electrospun nanofiber matrix was 
characterized by a dense infiltration of both neutrophils and mononuclear cells that surrounded 
and populated at the outer edges of the matrix at two weeks' time point. After six weeks, the 
electroconductive implant was more acellularized identified by more fast muscle growth in the 
center of matrices.  
 
Figure 75.Fast muscle infiltration on the Sub-acute repair with matrix six weeks post-surgery. A. 
Low magnification (left panels) shows 10X magnification. B. High magnification (20X) (right 
panels) shows 
A. Sub-Acute repair with matrix 
2wks 
B. Sub-Acute repair with 
matrix 6 wks 
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Based on this figure, native skeletal muscle (fast muscle) ingrowth could be identified in the 
center of matrix margins. This showed that this aligned conductive matrix could support muscle 
regeneration and growth.  
 
Figure 76.High magnification (20X magnification) shows fast muscle growth on matrices 
This figure further demonstrates that quite a lot of native skeletal muscle (fast muscle) ingrowth 
could be seen on the matrices.  
 
 
CD 31 staining 
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CD 31 staining 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
The H&E staining supported similar claims that the conductive matrix was almost wholly 
cellularized, showed islands of desman + cells along the interface with the underlying native 
muscle.  
 
Muscle vascularization on matrices 
 
Figure 77. Matrices implanted on muscle tendon tear only and repair with matrices 6weeks 
post-surgery 
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Figure 77.Sub-acute repair with matrix six weeks post-surgery. A. A region where matrices were 
implanted B. Other regions 
 
Traumatic injury in skeletal muscle will lead to loss of blood supply at the injury site. However, 
blood vessel plays a vital role in carrying nutrients and oxygen to the cells. In skeletal muscle, 
myoblasts have limited ability to proliferate and differentiate if they are more than 150 mm away 
from the blood vessel. Revascularization in the regenerative engineering is a critical step towards 
achieving successful regeneration of skeletal muscle[2]. Here based on the image of six weeks 
post-Sub-acute repair with matrix group, we can discover that more vascularization was present 
where matrices are inserted compared to the region where there are no matrices. This indicates 
the presence of matrices will require stimulation revascularization and promote muscle 
regeneration. 
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6.3.3 Acute rotator cuff repair 
6.3.3.1 Wet supraspinatus weight measurement 
 
 
Figure 78.Reduced supraspinatus percentage with Acute repair six weeks 
After six weeks, relative reduced supraspinatus percentage of the tendon tear only group (is 
statistically significant then acute repair (both with or without matrix). We can also observe that 
if the tendon is left untreated (14.86%)., it showed the very significant difference with the sham 
group (-1.983%, p<0.001). While the sham group showed significant with both repair 
groups(p<0.01). The tendon tears the only group also showed the statistical difference between 
two acute repair groups(P<0.05). There was no statistical significance between acute repair with 
suture (7.44%) 
Moreover, acute repair with matrix (8.14%). We can draw a similar conclusion that once the 
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tendon is being repaired, it showed better improvement than the tendon tear only group. 
6.3.3.2 Histology Analysis  
 
Figure 79.Hematoxylin and eosin staining of the rat supraspinatus muscle six weeks of acute repair 
 
Hematoxylin and eosin staining of the rat supraspinatus muscle showed most of the fibrosis on 
tendon tear group. The muscle cross sections were smaller after six weeks tendon tear compared 
to the sham group, with increased fibrosis of and irregular muscle structure. There is fibrosis 
present in both sub-acute repair groups but not as significant compared with tendon tear only 
group. Both acute groups showed better muscle organized six weeks after successful surgical 
repair. 
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Figure 80.Masson Trichrome staining of different groups at 6wks acute repair 
In the six weeks Masson Trichrome staining, a sham group has the most regular muscle structure 
and packing. Tendon tear group has wider gaps in between. It is further confirmed by showing 
dense packing of muscle fibers in groups which were repaired with matrices. 
A. Sham group B. Tendon tear only group 
C. Sub-acute repair D. Sub-acute repair 
with matrix 
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Figure 81.Gap area between muscle fascicles six weeks acute repair 
Similar to the sub-acute repair groups, tendon tear group had more gap between muscle fascicles 
with mean gap percentage around 20%, it was statistically higher than the rest of the groups. 
Sham group had the smallest gap area with mean 5%. It also showed a statistical difference 
compared with the rest three groups. Acute repair with matrix has slightly less gap percentage 
(10%) than sub-acute repair with suture repair only (15%) (p<0.01). The potential mechanism is 
that with the aid of the matrix, the stimulus effect prevents muscle gap from forming so that the 
average muscle area is more significant compared with suture only group. 
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Figure 82.Cell infiltration on matrices after six weeks acute repair A. H&E staining with 
matrices(5X) B. Masson Trichrome staining with matrices(5X) C. H&E staining with 
matrices(10X) D. Masson Trichrome staining with matrices(10X) 
Both H&E staining and Masson Trichrome staining showed that the conductive matrices were 
almost wholly cellularized, showed islands of desman + cells along the interface with the 
underlying native muscle.  
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Figure 83.Acute repair with matrix six weeks post-surgery. A. The region where matrices were 
implanted (5X) B. Other regions in supraspinatus muscle(5X) C. Region where matrices were 
implanted (10X) D. Other regions in supraspinatus muscle(10X) 
Similarly, based on the image of six weeks post-acute repair with matrix group, we can discover 
that more vascularization was present where matrices are inserted compared to the region where 
there are no matrices. This indicates the presence of matrices will require stimulation 
revascularization and promote muscle regeneration. 
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Figure 84.Fast muscle infiltration on the acute repair with matrices six weeks post-surgery. A. Low 
magnification (left panels) shows 5X magnification. B. High magnification (10X) (right panels) 
 
Based on this figure, traces of native skeletal muscle (fast muscle) ingrowth could be identified 
along the edges of matrices. This showed that this aligned conductive matrix could support 
muscle regeneration and growth.  
 
 
Figure 85.Muscle cross section measurement at six weeks using fast muscle staining 
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Similarly, we can find that the sham group showed statistically higher fast muscle fiber mean 
area of 3548± 91.84 um2 than the rest three groups(p<0.0001). Tendon tear group has a mean 
area of 1836 ± 91.99 um2. It has the smallest average fast muscle cross-section area compared 
with two acute repair group(p<0.001). Acute repair group with suture (mean 2430 ± 91.99 um2 ) 
has no significant difference compared with acute repair with matrices (mean 2537± 92.14 um2 
um2).  
6.4 Conclusions 
We have successfully developed a sub-acute rotator cuff repair model for our study. 
The results have demonstrated that detached supraspinatus muscle in this rat model changes 
significantly, with a decrease in muscle mass, a decreased cross-sectional area, and an increase in 
fat content. Type I muscle composition were deficient at two weeks' time points, but the sham 
group, Sub-Acute repair with matrix and Sub-Acute repair with suture only group were able to 
recover more type I muscle than the tendon tear only group. Besides, we showed that the 
increase in fat exhibited in the injury only model with a spatial pattern closer to the tendon 
attachment as compared with proximally.   
It was observed in our study that even there was a delay in surgical repair, overall muscle quality 
such as muscle fiber cross-section area and muscle irregularity can be improved, and there was 
less fibrosis compared to the tendon tear only group. Furthermore, the primary hypothesis of the 
current study is that by placing electroconductive matrices in the supraspinatus muscle after 
successful surgical repair, it can have a stimulating effect to promote muscle bundles to grow 
bigger. In this way, fatty infiltration is suppressed to some degree. So far, the positive impact of 
conducting polymer to promote muscle growth and differentiation have been confirmed in vitro 
by multiple research groups[5,104,109]. In our study, it was also observed that Sub-acute repair 
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of rotator cuff injury with electroconductive matrices revealed robust muscle growth and 
vascularization.  
We were the first one to test the hypothesis in vivo. The result showed a favorable outcome. 
Besides, previous studies have demonstrated that initial response to matrix implantation includes 
dense mononuclear cell infiltration which peaks at approximately two weeks post-surgery. The 
trend will be gradually decreasing afterward [20,21]. This cellular infiltrates mainly 
macrophages, the activation and temporospectral polarization of which is essential for muscle 
regeneration[208,268]. This progress will be followed by migration of myogenic progenitor to 
the injury site as a result of cytokines and chemokines released by the invading 
macrophages[208,268]. In our study, cell infiltration was observed two weeks post-surgery and 
continued to subside by six weeks following surgery. The matrix is acting as ‘stabilizer' to make 
supraspinatus muscle in place and prevent the formation of the gaps. Also, there were more 
vascularization as well as regenerated muscle cells growing on implanted electroconductive 
matrices at six weeks after surgical repair, indicating potential effect of matrices stimulating 
muscle growth following aligned electrospun nanostructure. Future study can also be done to 
explore that delay time between tendon tear and repair. For matrix repaired groups, there was 
less muscle gap and slightly higher muscle cross-section area compared with suture repair only.   
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Chapter 7. INTRODUCTION, CONCLUSIONS, AND FUTURE 
DIRECTIONS 
7.1 Introduction 
The field of regenerative muscle tissue engineering has come to provide the essential foundation 
for the next generation of clinically viable muscle graft substitutes. At the same time, the rising 
of conducting polymer has shown great promise in muscle as well as neural tissue 
regeneration[78][269][154]. As discussed in the introduction chapter, matrices were made 
biocompatible and biodegradable. Also, they are being combined with growth factors, drugs or 
morphogenetic proteins and cells. This combination of matrices, cells, chemical, morphological 
and biological features are critical elements in regenerative tissue engineering. Based on all those 
experience, the ambition in the scope of this research is to have more efficient conductive 
matrices with improved biological performance both in vitro and in vivo. 
The work in this thesis on electroconductive matrices have moved through the initial stages of  
a conductive polymer coating, modification, characterization, in vitro degradation, preliminary 
cellular evaluation, and intensive in vivo study and characterization. The broad hypothesis 
behind the design of this matrix was in part to capitalize on the benefits of both the alignment 
feature of electrospinning and optimum concentration of conducting polymer that would enhance 
the cell proliferation and encourage muscle differentiation. The initial analysis of this approach 
has been completed. After a careful assessment in vitro, we further evaluated the matrix in small 
animal’s models to evaluate the matrices performance, which is crucial for translational research.  
7.2 Conclusions 
In the scope of the thesis, a novel conducting polymer conducting polymer was successfully 
fabricated. A series material characterization was done to ensure the fabrication process was 
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successful and can be repeated. It was discovered that a combination of various guidance cues in 
the same matrix might provide a more biomimetic environment for tissue regeneration that is 
superior to inert matrices such as PCL matrices. Such electrospun composite nanofibers can 
simultaneously provide topographical and electrical cues to cells, highlighting the importance of 
the synergistic effects of these stimulatory cues for skeletal muscle tissue engineering. Then we 
used this optimized matrix for clinical study in rotator cuff models. Surgery wise, we found that 
it is better to treat rotator cuff injury promptly. However, even there is a delay in treating tear, 
the result suggested after a successful repair, the muscle condition, in general, was better than 
those untreated tendon tear groups. Also, regenerated muscle cells were growing on implanted 
electroconductive matrices at six weeks after surgical repair based on histology results, 
indicating the potential effect of matrices stimulating muscle growth following aligned 
electrospun nanostructure. Based on these results, it is very promising that a complex conducting 
polymer system, in a combination of electrical stimulation and satellite cells and deliver growth 
factors, can help further treat muscle atrophy in rotator cuff injury. 
7.3 Future directions 
Based on the study of muscle defect, there are two tracks that we can potentially pursue in the future. 
We can further improve the current system with muscle atrophy in rotator cuff model. An optimum 
amount of satellite cells and growth factors can be seeded on those electroconductive matrices to 
promote a higher level of regenerative properties. Besides, localized electrical pulse stimulation 
(EPS) mimicking the electrical cues in the in vitro niche, can be applied at localized muscle area to 
further promote myogenic differentiation of myoblasts and satellite cells on the matrix. Besides, in 
this study, we created a sub-acute repair model. Future modifications may include having a longer 
defect creation time, say three months or more. In that sense, we can see the effect of matrices on 
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chronic repair.   Another pitfall of the current study is that the observation time after surgery is too 
short. The matrices of the current research study already showed great compatibility and 
regenerative properties. It is expected that better surgical healing will be shown after three or more 
months post-surgery. 
We can further expand the project to volumetric muscle loss (VML). It is a hallmark of orthopedic 
traumatic or surgical loss of skeletal muscle with resultant functional impairment and no current 
standard of care[270][271]. More than 40% of the human body's mass consists of skeletal muscle, 
which possesses the ability of robust self-repair after injury[230][2]. However, when a large volume 
of muscle is lost as a result of trauma, the ability of skeletal muscle to regenerate usually fails[202].  
Trauma causes a tremendous burden of disease and injury all over the world. In the United States 
alone, it was shown that more than $400 billion was spent annually in association with medical costs 
and loss of productivity[200][272].  
Further, the majority of the trauma during combat operations in Iraq and Afghanistan is to the 
extremities and often associated with severe musculoskeletal injury[200]. The cost is tremendous 
because not only money was spent on treatment and rehabilitation, but also there is a separation of 
highly trained personnel from the military[273].  
The current standard approach for volumetric muscle loss is to use functional free muscle transfer. 
Although it looks promising, the procedures are complicated. The successful outcome of the surgery 
depends on highly skilled team member and proper patient location. What is worse, donor site 
morbidity issues and expertise to perform these surgeries poses a limitation to its widespread use. 
Last but not least, the results of usage of free tissue transfer have not always been promising for 
patients with combat extremity injuries[2][201]. Advances in the use of tissue engineering matrices 
and stem cells, hint at future therapeutic. However, the use of biologic matrix alone is limited 
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because it requires the presence of a nerve and remaining muscle construct[201]. Thus, it is critical 
to developing a newly engineered complex system that could regenerate a lost muscle part, 
improving the quality of life of thousands of veterans of the US considerably.  Here we propose to 
apply a regenerative tissue engineering method as an alternative approach not only to preventing 
scar tissue formation and restoring muscle function in moderate injuries, but also offering a highly 
potential treatment option for patients with a large volume muscle loss[2]. It is our vision to explore 
top-down engineering approaches using matrix-based tissue engineering in combination with the 
latest developments in stem cell science, developmental biology, and electric stimulation to study 
the muscle regeneration.  
Experience learned from matrix-based tissue engineering can, when incorporated with 
developmental and stem cell-based biology, controlled growth factor releases, and electrical 
stimulation, be applied to the regeneration of muscle constructs. 
In our previous study, we successfully fabricated conducting polymer coated matrices.  Both aligned 
and random electrospun nanofiber matrices are formed using 15 % (w/v) poly (ε-caprolactone) (PCL). 
Then dopamine is applied to the surface for 24 hours at pH 8.5 to polymerize onto the surface of 
PCL fiber mats, forming a polydopamine coating. This polydopamine coating can help to enhance 
the affinity of PCL fiber mats to muscle cells. Different concentrations of poly 
(3,4ethylenedioxythiophene): poly (styrene sulfonate) (PEDOT: PSS) (1%, 10%, 33%, 100%) were 
deposited onto surface-modified electrospun nanofiber matrices. Electroconductive nanofiber 
matrices with tunable conductivity were successfully achieved. Further, based on an accelerated rate 
of innervation of skeletal muscle in a severe hindlimb ischemia model by treating with IGF or 
VEGF[136], It is further hypothesized that incorporation of growth factors such as IGF or VEGF 
into matrices can further improve healing of VML.  
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Based on our preliminary study, it has been shown that even without external electrical stimulation, 
conducting polymer matrices have promoted more myotube formation, and alignment has helped 
form longer and more mature myotubes. It is further hypothesized that electrical pulse stimulation 
(EPS) mimicking the electrical cues in the in vitro niche, will further promote myogenic 
differentiation of myoblasts and satellite cells on the matrix. 
Also, we hypothesize that a conducting polymer system, in a combination of electrical stimulation, 
can efficiently carry satellite cells and deliver growth factors, can help muscle regeneration in VML 
model (see Figure 3). We will first isolate satellite cells, seeded it on conducting polymer matrices, 
which already incorporated growth factors. Then the complex matrix will be inserted into VML area, 
and proper electrical stimulation following protocol will be given.   
 
 
Figure 86.Schematic illustration of approaches of multi delivery matrix system and electrical 
stimulation to treat volumetric muscle loss 
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7.4 Objectives 
The specific objectives of this proposal are: 
Aim #1: Fabricate a PEDOT: PSS/PCL composites matrices releasing growth factors.  
Our lab has successfully demonstrated that electrically conductive materials, in combination with 
geometrically aligned electrospun nanofibers enhanced both myoblast differentiation and 
ultrastructural organization without the need for external electrical stimulation.  We will further 
incorporate factors such as IGF or VEGF into matrices by either co-electrospinning or surface 
absorption. The release profile will be characterized using Elisa or HPLC. Toward this goal, in the 
end, we will be able to have controlled the release of the growth factor in this biodegradable 
electrically conducting matrix /growth factor system. The controlled release matrices will be 
characterized using Scanning Electron Microscopy (SEM), X-ray photoelectron spectroscopy (XPS), 
and contact angle analysis. The effects of topographic cues, electrical cues, and growth factors cues 
on cellular morphology, proliferation, and myogenic differentiation will be studied using a cell 
viability assay, live/dead staining, proliferation (MTS, DNA assay or Ki67), RT-PCR (Real-Time 
Quantitative Reverse Transcription PCR) and immunohistochemistry 3. 
Aim# 2: To evaluate the in vitro effects of electrical stimulation on satellite cells proliferation and 
differentiation cultured on the aligned electrically conducting matrix. 
Satellite cells, an adult stem cell population are capable of regenerating new muscle[136]. Using an 
established protocol for satellite cell isolation, we will harvest satellite cells from rats and seed them 
on electroconductive matrices. According to previous protocol, continuous EPS parameter ranging 
from 0.1–0.5 V/mm pulse amplitudes, 0.5–2 Hz frequencies will be applied[274]. Force production 
characterized using physiological parameters such as peak twitch force (Pt) will be recorded and 
analyzed[274]. The effects of electrical stimulation on cellular morphology, proliferation, and 
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myogenic differentiation will be studied using cell viability assay, live/dead staining, RT-PCR 
(Real-Time Quantitative Reverse Transcription PCR) and immunohistochemistry. At the end of this 
aim, we will be able to evaluate and determine the efficacy of electrical stimulation on myogenic 
differentiation in vitro using an established protocol. 
Aim#3: To assess the cellularity and muscle formation of the electroconductive nanofiber matrix 
determined in standard VML rat model in vivo under electrical stimulation and stem cell, growth 
factor delivery. 
Rat TA muscle VML injury will be created. Briefly, a punch biopsy will be performed through the 
middle third of the TA muscle, and around 20% biopsied tissue will be removed[171]. Multi 
delivering muscle cell patches created and improved in aim 1 and aim two will then be transplanted 
in the defect area. Then electrical stimulation will be applied to treatment groups. Specimens (n=6) 
for In vivo functional assessment will be performed. In brief, in vivo neural evoked torque of isolated 
TA muscles will be measured between VML rats treated with electrical stimulation and VML control 
rats[171].  To assess engraftment, rats will be euthanized, and muscles will be harvested at four 
weeks and eight weeks post-transplantation for analysis. Muscle histology sections will be stained 
with hematoxylin and eosin (H&E), and oil red O, to assess tissue structure cellularity as well as fat 
deposition(n=3)[171]. At the end of this aim, we will have established the efficacy of a 
biodegradable electrically conducting matrix/stem cell/growth factor system with electrical 
stimulation in healing a volumetric muscle loss. We expect that the mechanical stability and ES 
offered by the degradable matrix and the delivery of stem cells, growth factor would significantly 
improve the functionality of muscle. 
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7.5 Impact of the project 
Muscle conditions are not to be neglected. The impact of VML on the general population is 
significant as muscle conditions rank among the top 10 most frequent unfitting conditions[271]. 
According to the U.S. Army Institute of Surgical Research, in an orthopedic-specific population 
(limb salvage type III tibia fracture) muscle conditions (VML) account for 65 percent of disability. 
Failure to address those soft-tissue deficits could result further in poor surgical recovery. VML 
contributes to >90 percent of muscle conditions that lead to long-term disability when considering 
patients who have been medically retired because of various injuries[273][200].  
Transfer and engraftment of muscle flap are currently well-established clinical approaches, but 
they have many limitations such as donor site morbidity and longer rehabilitation times[242]. This 
proposal represents an alternative treatment that can improve the surgical outcome of patients. In 
short-term, we will be able to create a complex engineering system that incorporates muscle cell 
mimicking nano features, stem cells and growth factor and electrical stimulation that will provide 
a competent platform with self-regenerative capacity for muscle regeneration. So far, not many 
research groups have been looking at clinically available complex muscle regeneration systems 
that are electrically powered. Based on our lab expertise, we will continue to develop a novel 
conducting polymer matrices with controlled growth factor release. We will work with clinicians 
and surgeons to utilizing electrical stimulation simultaneously treat volumetric muscle loss and 
monitor in real-time pathological progression and regression. The high impact of this proposal will 
address fundamental issues in musculoskeletal regeneration.  
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Electroconductive nanofiber scaffolds for muscle regenerative engineering 
Xiaoyan Tang1,2,3, Yusuf Khan1,2,3 ,Cato Laurencin1,2,3,*, 
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Statement of Purpose: Skeletal muscle has the robust ability to 
regenerate after minor injury, but is limited in the case of large 
volume of muscle loss due to trauma or chronic disease. The 
current standard approach for treating volumetric muscle loss 
involves either tissue debridement or muscle transposition. 
However both procedures present a host of issues such as donor 
site morbidity and incomplete recovery of pre-injury muscle 
strength and functionality1. Here we propose a novel, alternative 
approach to muscle tissue engineering that has the potential to 
restore muscle function in moderate injuries with minimal to no 
scar formation but may also offer a regeneration strategy in the 
case of large volume muscle loss. Our goal in this study was to 
modulate the cellular physical microenvironments to allow 
the application of controlled electric impulses via 
electroconductive nanofiber scaffolds to generate a more 
robust and functional muscle construct for muscle 
regeneration. 
Material and Methods: A conducting polymer, 
poly(3,4ethylenedioxythiophene):poly(styrenesulfonate) 
(PEDOT:PSS), was deposited onto surface-modified electrospun 
nanofiber matrices (Fig 1) that were formed using a 15 % (w/v) 
poly(ε-carprolactone) PCL solution at 2.5 mL/min flow rate, and 
1 kV/cm-1 potential at ambient temperature and humidity to 
obtain bead-free nanofibers. Then 2mg/ml dopamine was 
applied to the surface for 24 hours at pH 8.5 to polymerize onto 
the surface of PCL fiber mats to form a polydopamine coating2. 
The modified DOPA-PCL surfaces were washed, dried, and 
subsequently coated with 1% PEDOT:PSS, 10% PEDOT:PSS, 
33%  PEDOT:PSS, and 100% PEDOT:PSS solution, where the 
100% solution indicates a PEDOT:PSS 1.3wt% dispersion in 
H2O and 33%, 10%, 1% are further diluted with PBS.  The dried 
scaffolds were treated with mild acid to enhance its 
conductivity. Scaffolds were characterized using Scanning 
Electron Microscopy (SEM), X-ray photoelectron spectroscopy 
(XPS), and contact angle analysis. To determine the in vitro 
biocompatibility, C2C12 myoblast cells were cultured on the 
substrates. The effects of topographic cues and electrical cues on 
cellular morphology, proliferation and myogenic differentiation 
were studied using a cell viability assay, live/dead staining, RT-
PCR (Real-Time Quantitative Reverse Transcription PCR) and 
immunohistochemistry 3. 
Results and Discussion:  Electroconductive nanofiber scaffolds 
with tunable conductivity were successfully fabricated. Four 
point probe conductivity testing substantiated that the 
conductivity could be controlled by modifying the concentration 
of PEDOT:PSS applied on scaffolds. The 100% group possessed 
an average sheet resistance value of ~5× 104, while the 
conductivities of the 33% and 10% group were 13× 105 and 17× 
106, respectively. The results of in vitro cell viability assays 
suggested that PEDOT:PSS coating exhibited no toxicity. 
PEDOT:PSS at 1% and 10% showed stimulatory effect on 
C2C12 growth. RT-PCR showed that at 10% PEDOT:PSS, 
nanofibers promoted myogenic differentiation as shown by 
upregulation of myogenic regulatory factors Myf5,MyoD, 
myogenin(MyoG), troponin T type 1(Tnnt1). Fluorescent 
images (Fig 2) also shows that addition of conducting polymer 
promoted myotube formation. 
  
Conclusions:  We have successfully developed a novel method 
for fabrication of electroconductive nanofiber scaf-folds.  
PEDOT: PSS coating of low and medium concentration(1% and 
10%) showed stimulatory effect on C2C12 growth and are more 
effective in promoting myoblast differentiation. 10% 
PEDOT:PSS promoted myotube formation the most than control 
groups. There is a combination of topographical and electrical 
guidance cues that have effects on C2C12 differentiation and 
need further investigation. 
References:  
1.Qazi, T.Biomaterials. 2015;53:502-521. 2.Lee, H. 
Science.2007; 318(5849), 426–30 3.Yang H S. Advanced 
healthcare materials. 2015. 
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Figure 1. Schematic illustration of the conducting polymer coated 
scaffolds.  
Figure 2. Representative fluorescent 
images of C2C12 cultured on a) 10% 
PEDPT:PSS coated scaffolds b) 
Dopamine-PCL scaffolds c) Pure PCL 
scaffolds at day 8. Cells were stained for 
sarcomere-myosin heavy chain (green) and 
nuclei(blue).  
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Multifunctional Electroactive Matrices Have the Ability to Promote Muscle Regeneration 
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Introduction: The current standard clinical approach to treat muscle volumetric loss is to transfer and 
engraft healthy, vascularized, and innervated autologous tissue. However, this method has the issue of 
morbidity and there is no total recovery to pre-injury muscle strength and functionality. Therefore, there 
is a growing requirement to understand muscle cell behaviour and to fabricate muscle tissues that mimic 
native muscle tissue structure. For instance, electrical stimulus is used as one of the ways to stimulate 
tissue repair and regeneration. In the area of regenerative engineering, this is mainly done by engineering 
smart bioelectronics on conducting polymers as biomaterials, or part of a biomaterial, to provide the 
needed electrical stimulus.  
 
Materials and Methods: The multifunctional electroactive matrix consists of the conducting polymer, 
poly (3,4ethylenedioxythiophene): poly (styrenesulfonate) (PEDOT: PSS), with a biodegradable 
polymer substrate poly (ε-carprolactone) (PCL), which is rationally assembled together. To fabricate this 
flexible electroconcondutive scaffold, both aligned and random electrospun nanofiber matrices are 
formed using 15 % (w/v) PCL. Then dopamine is applied to the surface for 24 hours at pH 8.5 to 
polymerize onto the surface of PCL fiber mats, forming a polydopamine coating. This polydopamine 
coating can help to enhance the affinity of PCL fiber mats to muscle cells. Different concentrations of 
PEDOT: PSS (1%, 10%, 33%, 100%) were deposited onto surface-modified electrospun nanofiber 
matrices.  Electroconductive nanofiber scaffolds with tunable conductivity were successfully achieved. 
To determine the in vitro biocompatibility, C2C12 myoblast cells were cultured on the substrates. The 
effects of topographic cues and electrical cues on cellular morphology, proliferation and myogenic 
differentiation were studied using a cell viability assay, live/dead staining, RT-PCR (Real-Time 
Quantitative Reverse Transcription PCR) and immunohistochemistry. We further isolated mouse 
satellite cells using FACs and cultured them on the scaffolds listed above, then SEM, live/dead staining, 
immunohistochemistry were so far used to characterize these scaffolds. 
 
Results and Discussion: Four-point probe conductivity testing substantiated that modifying the 
concentration of PEDOT: PSS applied on the matrices could control conductivity. The 100% group 
possessed an average sheet resistance value of ~5× 104, while the conductivities of the 33% and 10% 
group were 13× 105 and 17× 106, respectively. Myotubes were more aligned and organized on the 
aligned nanofiber matrices. Further studies demonstrated that these electroactive substrates were 
biocompatible both on C2C12 myoblast and mouse satellite cells. They facilitated muscle cell adhesion 
and proliferation. Based on study of cultured C2C12 cells, an optimum PEDOT: PSS coating 
concentration (10%) was found to be effective in promoting myoblast differentiation due to its intrinsic 
conductivity. Mechanistically, differentiation proceeded via an upregulation of myogenic regulatory 
factors, Myf5, MyoD, myogenin (MyoG), and troponin T type 1(Tnnt1). Fluorescent images) also shows 
that addition of conducting polymer promoted myotube formation. 
 
 
 
Figure 1. Schematic illustration of conducting polymer coated 
scaffolds 
 
 
Conclusions: There are topographical and electrical guidance cues that have effects on muscle 
differentiation and these studies have helped to elucidate them. This self-responsive bioelectronics matrix 
system demonstrated the ability to independently electrically stimulate muscles cells and regulate muscle cell 
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Introduction: Rotator cuff tears of the shoulder are the most common and challenging orthopedic problem. Tendon tear not only leads to 
pain, but can also cause tendon thinning and retraction, fatty infiltration as well as muscle atrophy, resulting subsequent loss in shoulder 
stability and function. Surgical repair of tendon can be performed to restore a strong connection between the bone, tendon, and muscle. 
However, commonly there will be delay between the time of injury and surgical repair. This could slow down or inhibit the healing process, 
resulting in weak, fatty muscles even after repair. Multiple research groups have been studying the process of muscle atrophy after tendon 
tear. In our case, we are studying muscle quality after chronic rotator cuff repair. More importantly, we are proposing there is a positive 
effect with implantation of aligned intrinsically conductive muscle scaffolds during surgical repair on supraspinatus muscle. It can act as a 
guide and stimulator for muscle regeneration, thus suppressing fatty formation. The incorporation of the scaffolds would result in a higher 
level of muscle regeneration and regenerate a morphologically superior enthuses in a rat model of chronic rotator cuff degeneration. 
Methods: We previously observed high differentiation of skeletal muscle cells on optimized aligned electrically conductive poly(3,4-
ethylenedioxythiophene) polystyrene sulfonate (PEDOT: PSS) scaffolds during in vitro. In this study, we have developed a chronic rotator 
cuff repair model utilizing adult male Sprague Dawley rats weighing between 400 grams to 450 grams. We first used an open surgical 
approach to create a full-thickness rotator cuff tear of supraspinatus tendon. After chronic (42 days) tear, we went back and performed 
surgical repair of supraspinatus tendon to 20 animals with or without the insertion of PEDOT: PSS scaffolds at the same time. Briefly, 
during tendon repair, a small incision is made through the trapezius muscle at the scapular spine, exposing the midbelly of the 
supraspinatus (SS) muscle. Then, a 0.6cm(length)*3 cm (width) PEDOT: PSS scaffold was sutured into the belly of the SS to induce a 
cycle of regeneration. Supraspinatus, infraspinatus and control supraspinatus tendon and muscle were exposed and removed for 
histological analysis at certain time points after procedure. We then measured changes in muscle mass, tendon length, and the number of 
fibers of fast type muscle and slow type muscle. Differences between groups were tested using a one-way ANOVA followed by Tukey’s 
post hoc sorting. The surgical groups are listed as follows: Group 1: (control 1) Sham surgery, sacrificed at 2 weeks(n=3) and 6 
weeks(n=3). Group 2: (control 2): Rotator cuff acutely injured without repair, sacrificed at week 2(n=4), week 6(n=4). Group 3: Rotator 
cuff acutely injured, 6 weeks later repaired with suture, sacrificed at week 2(n=4), week 6(n=6). Group 4: Rotator cuff acutely injured, 6 
weeks later repaired with suture and place 10% PEDOT: PSS nanofiber scaffolds on supraspinatus muscle, sacrificed at week 2(n=4), 
week 6(n=6) 
Results: We used reduced supraspinatus percentage to measure supraspinatus weight loss on the surgical side compared to the nonsurgical 
side (Fig. 1). The equations listed as follows: Reduced supraspinatus percentage= (Control supraspinatus weight- surgical supraspinatus 
weight)/Control supraspinatus weight. For sham groups, they went through minimal supraspinatus weight loss at 2 weeks compared to 
other groups. At six weeks, the wet weight of surgical supraspinatus is higher than control supraspinatus, indicating potential complete 
healing of muscle. For tendon tear only groups, the average reduced supraspinatus percentage is statistically greater than other groups (at 
least p<0.05) at two weeks as well as six weeks. It is noticeable that after rotator tendon is being repaired, the difference of weight loss 
between surgical side and control side is much smaller than tendon tear groups at two weeks and six weeks. However, no significant 
difference was observed between chronic repair and chronic repair with scaffold groups in the reduced supraspinatus percentage. 
Hematoxylin and eosin staining of the rat supraspinatus muscle (Fig. 2 A-D) demonstrated morphologic changes in the transected rotator 
cuff muscle compared to control sham groups. The muscle cross sections were smaller after six weeks tendon tear compared to sham 
group, with increased fibrosis of and irregular muscle structure. There are fibrosis present in both chronic repair groups but not as 
significant compared with tendon tear only group. The muscle fiber looked organized and compact 6 weeks after successful surgical repair. 
(Fig. 2 E) demonstrates fast muscle growth on scaffold, indicating potential muscle regeneration on electrically conductive scaffolds.  
Discussion: We have successfully developed rat chronic rotator cuff repair model for our study.  It was discovered that even there was a 
delay in surgical repair, overall muscle quality such as muscle fiber cross section area and muscle irregularity can be improved, and there 
was less fibrosis compared to tendon tear only group. Future study can also be done to explore that delay time between tendon tear and 
repair. Also, there were regenerated muscle cells growing on implanted electro conductive scaffolds at 6 weeks after surgical repair, 
indicating potential effect of scaffolds stimulating muscle growth following aligned electrospun nano structure.  
Significance: In clinical settings, surgical success of a chronic rotator cuff tendon repair is sometimes compromised by muscle quality. 
This study showed that in rat chronic rotator cuff model, muscle atrophy can be alleviated by successful surgical repair. Further, with the 
evidence of muscle regeneration on scaffolds, there is huge potential that a new class of intrinsic conductive scaffolds can stimulate muscle 
growth and suppress fatty infiltration. Muscle regenerative engineering can be a promising clinical treatment in rotator cuff injury.   
References: (1) Liu, X.; Manzano, G.; Kim, H. T.; Feeley, B. T. A rat model of massive rotator cuff tears. J. Orthop. Res. 2011, 29 (4), 
588–595 DOI: 10.1002/jor.21266. (2)  Barton, E. R.; Gimbel, J. a; Williams, G. R.; Soslowsky, L. J. Rat supraspinatus 
muscle atrophy after tendon detachment. J. Orthop. Res. 2005, 23 (2), 259–265 DOI: 10.1016/j.orthres.2004.08.018. 
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for funding this work. Dr. Laurencin is a recipient of the National Medal of Technology. 
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APPENDIX B. SURGERY DETAILS AND PROTOCALS 
Surgery procedures 
Several sterile instrument packets will be utilized to minimize the repeat use of any instruments. 
If necessary, however, the Instrument will be sterilized with the use of a bead sterilizer. 
  
Procedure 1: Rotator cuff tear:  
 Operative Details: 
In all groups only one shoulder will be operated per rat.   After the shoulder is adducted, a 1 – 3 
cm longitudinal incision will be made with a #15 blade on the lateral border of the acromion to 
reflect the skin. An incision will be made along the lateral border to separate the trapezius and 
deltoid muscles from the acromion and spine of the scapula. Once the muscle is exposed the 
subsequent surgical procedures will vary based on the particular experimental group. Each group 
and associated procedure is listed below: 
  
Group 1 - Sham: The rotator cuff tendons will be exposed but left uninjured and the underlying 
tissue and skin will be closed (see “Wound Closure” below).  Animals will be sacrificed 2, 4, 6, 
8, and 12 weeks after the sham procedure. 
  
 Group 2 -  Full Tendon Tear with no repair:  A tunnel will be created in the cortical bone under 
the insertion of the supraspinatus tendon. The supraspinatus will then be detached from its 
insertion point using a #11 blade. The underlying tissue and skin will be closed (see “Wound 
Closure” below). 
 
Group 3, 4, 5, and 6 – Full Tendon Tear with Immediate Matrix Repair:  
Tendon tears will be created as described above and repair will have done immediately with 
procedure 2, surgical site closed as described below. 
 
Groups 7-14– Full Tendon Tear with Matrix Repair Two weeks, Six Weeks Post Tendon Tear:  
Tendon tears will be created as described above and the surgical site closed as described below. 
 
 Wound Closure: The muscle and skin layer will be closed with 4-0 vicryl using interrupted 
suture technique. The skin layer may be alternatively closed using a subcuticular suturing 
technique. Gluture® may be used to seal the edges of the wound. The animal may be placed in a 
collar and/or chew guard may be used as a deterrent to prevent the animal from opening the 
wound, thus, aid healing. If staples or non-degradable sutures are used in the surgery, they will 
be removed 10 – 14 days post-operatively. 
 
Procedure 2: Rotator cuff repair  
 
Rotator cuff repair: At this point, a 5-0 double loaded prolene suture will be introduced into the 
supraspinatus muscle and a Masson-Allen or other appropriate stitch sewn into the belly of the 
muscle, terminating about 2 – 5 mm from the tendon insertion. The supraspinatus will then be 
detached from its insertion point using a #11 blade. A 0.3 – 1.5mm tunnel will be drilled into the 
bone as described above without damaging other muscles. The suture will be passed through the 
tunnel and tied down to hold the supraspinatus muscle. Concurrently, either a nanofiber matrix or 
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surgical reattachment with no matrix will be placed between supraspinatus and subscapularis 
muscle. 
  
 Group 3, 4, 5, and 6 – Full Tendon Tear with Immediate Matrix Repair: As described above, 
immediately after the tendon tear procedure a tunnel will be created in the cortical bone under 
the insertion of the supraspinatus tendon. Concurrently, either a PCL nanofiber matrix (group 3), 
1% PEDOT: PSS coated PCL matrix (group 4), 10% PEDOT: PSS coated PCL matrix (group 5), 
or surgical reattachment with no matrix (group 6) will be placed between supraspinatus and 
subscapularis muscle. The defect will then be repaired with No. 5 Prolene tapered needle suture, 
approximating the torn tendon back to the humerus and the underlying tissue and skin will be 
closed (see “Wound Closure” below). 
  
 Groups 7, 8, 9, and 10 – Full Tendon Tear with Matrix Repair Two Weeks Post Tendon Tear: 
Two weeks after the tendon tear procedure a tunnel will be created in the cortical bone under the 
insertion of the supraspinatus tendon and animals will have matrices implanted and the tendon 
reattached as described for groups 3, 4, 5, and 6 and the underlying tissue and skin will be closed 
(see “Wound Closure” below).  Animals are sacrificed either 2 or 6 weeks after matrix 
implantation. 
  
 Groups 11, 12, 13, and 14 – Full Tendon Tear with Matrix Repair Six Weeks Post Tendon Tear:  
Six weeks after the tendon tear procedure a tunnel will be created in the cortical bone under the 
insertion of the supraspinatus tendon and animals will have matrices implanted and the tendon 
reattached as described for groups 3, 4, 5, and 6 and the underlying tissue and skin will be closed 
(see “Wound Closure” below).  Animals are sacrificed either 2 or 6 weeks after matrix 
implantation. 
  
 Wound Closure: The muscle and skin layer will be closed with 4-0 vicryl using interrupted 
suture technique. The skin layer may be alternatively closed using a subcuticular suturing 
technique. Gluture® may be used to seal the edges of the wound. The animal may be placed in a 
collar and/or chew guard may be used as a deterrent to prevent the animal from opening the 
wound, thus, aid healing. If staples or non-degradable sutures are used in the surgery, they will 
be removed 10 – 14 days post-operatively. 
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